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Genome-wide association studies have recently proved to be a promising and 
powerful approach in the discovery of single nuclear polymorphisms (SNPs) which are 
related to type 2 diabetes mellitus (T2DM). However, traditional statistical approaches 
that are applied in genome-wide association studies are often confronted with high-
leveled computational complexity during the selection of significant SNPs and sometimes 
may achieve a low sensitivity. In this study, various machine learning techniques were 
introduced to screen T2DM-related SNPs through a canonical two-stage case-control 
design of genetic analysis. We also compared the performances achieved by traditional 
statistical approaches and these learning techniques. 
The database applied in this study included 1895 SNPs (genotypes), 17 clinical 
physiological and biochemical factors (phenotypes) and 776 samples. Before starting the 
two-stage genetic analysis, we introduced self-organizing maps (SOM) and K-means 
clustering to analyze the subclasses of samples based on their phenotypic information 
only, by which we created ten pairs of two independent sample sets for the two stages 
i 
respectively. The created sample sets displayed similar distribution on the principal 
components of phenotypes. In the first stage of this study, 1895 SNPs were investigated 
in one sample set containing 223 cases and 138 controls through random forests (RF) and 
around a hundred candidate SNPs were selected out for further analysis in the next stage. 
In the second stage of this study, candidate SNPs were examined again in the other 
sample set containing 228 cases and 145 controls via allelic chi-square test. We run the 
same procedure on each pair of created sample sets by SOM and K-means clustering and 
counted the number of hits for candidate SNPs in the second stage among the ten 
individual experiments. Cumulative effects of candidate SNPs with multiple hits on the 
risk of type-2 diabetes were investigated. Performance of our two-stage approach and 
traditional chi-square test were also compared to each other. 
The results of this study demonstrated that 1) application of SOM and K-nieaiis 
clustering in advance of the association study helps improve the possibility of replicating 
candidate SNPs in the second stage; 2) our two-stage approach detected eight major 
candidate SNPs for type-2 diabetes after the second stage. Six of the eight candidate 
SNPs from different genes were further analyzed. There were stepwise increase in risk of 
type 2 diabetes with the number of carried risk alleles among the candidate SNPs; 3) our 
two-stage approach was confirmed comparable with and more conservative than 
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CHAPTER 1. Introduction 
CHAPTER 1. Introduction 
1.1. Introduction of genetic association studies 
One main objective of genetic association studies is to discover disease-related 
alleles by comparing distributions of the alleles between affected and unaffected 
individuals in a population without apparent stratification (Figure 1.1). An association 
study involves two distinct groups. One is composed of patients or affected individuals 
and the other is composed of normal people or unaffected individuals. Using standard 
statistical analysis tools such as chi-square test on a 2x2 contingency table or logistic 
regression, researchers have been able to detect risk-conferring alleles with a higher 
frequency in case subjects and a lower frequency in control subjects followed by future 
validation and functional studies. Hitherto, the "golden standard" to judge positive 
associations is the p-value of each allele defined by the statistical tests used in association 
studies. The p-value of the risk association of a disease with an allele should be 
statistically significant, which may suggest a causal relationship. In association studies of 
candidate genes with known function, risk-conferring variants within exons, promoter, 
enhancer and other regulatory regions can often be explained due to their effects on gene 
transcription and protein translation. On the other hand, biological significance of risk-
conferring genetic variants within introns or intergenic regions is more difficult to explain 
(Lander and Schork 1994). One possibility is that these intronic variants might be in 
linkage disequilibrium with other real casual mutations. Alternatively, these genetic 
variants may influence transcription and translation of genes although their functions 
have yet to be elucidated. Indeed, over 90% of the human genome are non-coding and 
1 
CHAPTER 1. Introduction 
some of these non-coding RNAs may regulate cellular structure and functions to 
influence various phenotypes (Glinsky 2008). 
In the study of complex diseases, variants of candidate genes only account for a 
small fraction of disease heritability. To date, researchers have extended their research 
scope to interrogate the whole human genome, using "genome-wide association studies" 
(GWAS) (Hirschhorn and Daly 2005). Compared to candidate-gene approach, GWAS 
enables researchers to discover novel disease-associated genetic variants in both coding 
and non-coding regions. With advancing technology and increasing affordability 
(Hirschhorn and Daly 2005), GWAS have become an increasingly popular tool in these 
discovery work. 
Aside from single nuclear polymorphisms (SNPs), other types of genomic 
structural variations such as copy-number variants (CNV) have also been found to be 
associated with different disease phenotypes. These include HIV acquisition and 
progression, lupus glomerulonephritis and three systemic autoimmune diseases including 
systemic lupus erythematosus, microscopic polyaiigiitis and Wegener's granulomatosis 
(McCarroll and Altshuler 2007). Although there are still technical challenges in the 
genotyping and analysis of CNVs (McCarroll and Altshuler 2007), many researchers are 
now embarking upon CNV-based association studies to detect effects of CNVs on disease 
phenotypes (Yang et al. 2008; Kathiresan et al. 2009). 
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Association studies 
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Figure 1.1: Main concepts of genetic association studies. Adapted from Lander and 
Schork, 1994 (Lander and Schork 1994) 
1.1.1. Application of genetic association studies in complex diseases 
The introduction of GWAS in medical genetics has led to the discovery of an 
increasing number of genetic variants associated with complex diseases. These 
discoveries have also deepened our understanding of the genomic architecture and its 
inheritability and association with multifactorial traits, such as asthma and atopic diseases 
(Hoffjan et al. 2003)，stroke (Dichgans and Markus 2005), type 1 and (Field 2002) and 
type 2 diabetes (Frayling 2007)，schizophrenia (O'Donovan and Owen 1999), various 
types of cancer (Pharoah et al. 2004) and immune-mediated diseases (Xavier and Rioux 
2008), to name but a few. Among these complex disorders, more disease-susceptibility 
genetic variants were discovered for diabetes (type 1 and type 2) and cancer than for 
asthma and coronary heart disease (McCarthy et al. 2008). Aside from the discovery of 
disease-related genetic loci and SNPs for complex diseases, a considerable number of 
genetic variants has been found to be associated with important continuous clinical traits, 
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such as low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol 
(HDL-C) or triglycerides (TG) (Kathiresan et al. 2009), adult and childhood height 
(Weedon et al. 2007) and body mass index (BMI) (Frayling et al. 2007). These 
systematic, well-designed, whole-genome based surveys on the relationships between 
genetic variants and complex diseases have led to novel disease pathways and greatly 
advanced our understanding of disease mechanisms. 
1.1.2. Application of genetic association studies in type 2 diabetes 
Type 2 diabetes was once considered a 'nightmare' for geneticists and despite 
many years of research, few genetic variants have been found to be directly related to this 
disease (O'Rahilly et al. 1988). However, the use of both candidate-gene based and 
genome-wide association studies have led to the discovery of risk-conferring 
chromosomal regions and SNPs which are relevant to type 2 diabetes. Some of these 
candidate genes are found to be targets of anti-diabetic drugs including the KCNJ 11 
(potassium inwardly-rectifying channel, subfamily J, member 11) and PPARG 
(peroxisome proliferator-activated receptor-y) genes. As a target of the long standing 
anti-diabetic drug, sulphonylurea, KCNJ 11 is the coding gene of one component of a 
transmembrane potassium channel which plays a critical role in beta-cell physiology. On 
the other hand, PPARG gene encodes a transcription factor related to differentiation of 
adipocytes and is a primary target of a new class of anti-diabetic drug, thiazolodinedione 
(Frayling 2007). Other type 2 diabetes-related common variants discovered in candidate-
gene based association studies include the transcription factor 2, hepatic (TCF2) and the 
Wolfram syndrome 1 (WFSl) genes (Frayling 2007). Recent large scale GWAS in 
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multiple populations have led to discovery of seven more gene regions related to type 2 
diabetes and novel disease pathways (Frayling 2007). These include the C D K A L l 
(CDK5 regulatory subunit-associated protein 1-like 1), CDKN2A/2B (cyclin-dependent 
kinase inhibitor 2A/2B), FTO (fat mass and obesity-associated gene), HHEX 
(haematopoietically expressed homeobox), IDE (insulin-degrading enzyme), IGF2BP2 
(insulin-like growth factor 2 niRNA-binding protein 2), SLC30A8 (solute carrier family 
30 (zinc transporter), member 8), and TCF7L2 (transcription factor 7-like 2 (T-cell 
specific, HMG-box)) (Frayling 2007). 
Table 1.1 shows the time frame when these eleven risk-conferring regions for 
type 2 diabetes were discovered. Among these findings, TCF7L2 is the only gene 
discovered by both candidate-gene based approach and GWAS, while the majority were 
discovered using the latter approach thus highlighting the power of GWAS in uncovering 
disease-related genetic variants in unknown candidate genes. The risk association 
between type 2 diabetes and TCF7L2 was discovered using family-based linkage analysis 
followed by sequencing for common variants within the susceptible loci and association 
studies. Family-based linkage analysis is commonly implemented in an early stage of an 
association study, leading to genetic loci that are susceptible to the disease. This is 
followed by sequencing or genotyping within uncovered candidate loci to detect actual 
genetic markers for the disease. This systematic approach has led to the discovery of 
linkage of type 2 diabetes to a susceptible locus on chromosome lOq (Duggirala et al. 
1999; Reynisdottir et al. 2003). Further interrogations of the region using high density 
microsatellite markers has uncovered certain genetic variants that are associated with 
type 2 diabetes, including one microsatellite marker DG10S478, together with several 
5 
CHAPTER 1. Introduction 
SNPs within an LD block that spans part of intron 3, complete exon 4 and part of intron 4 
of TCF7L2 gene (Grant et al. 2006). This approach has become one of the mainstream 
analytical methods in genetic analysis and led to discovery of type 2 diabetes-associated 
genetic variants. 
Gene Year of discovery Candidate gene Non-candidate gene 
based approach based approach 
PPARG 2000 + 
K C N J l l 一 2003 + 
TCF7L2 一 2006 + + 
TCF2 — 2007 + 
WFSl 2007 + 
IGF2BP2 2007 + 
C D K A L l 一 2007 + 
SLC30A8 2007 + 
HHEX-IDE 2007 — + 
FTP 2007 + 
CDKN2A-2B 2007 + 
Table 1.1 Overview of eleven new target genes that are associated with type 2 diabetes. 
Column 3 & 4 indicate the corresponding gene was found to be associated with type 2 
diabetes by either candidate gene based approach or genome-wide based approach. Note 
that TCF7L2 was discovery in 2007 by both approaches. Adapted from Frayling, 2007 
(Frayling 2007). 
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1.2. Study designs of genetic association studies 
Although the cost for GWAS has greatly decreased in recent years, it still 
represents a substantial amount of expenditure for most researchers and simply 
unaffordable for some research groups. In GWAS, hundreds of thousands of SNPs are 
required to be genotyped for each individual. While using a smaller sample size may 
limit the cost, this may reduce the power of the study to detect causal genetic variants and 
increase the number of false positive signals. For complex diseases like type 2 diabetes, 
many genetic risk factors have only small effect size which can be further attenuated by 
environmental and/or lifestyle factors. These confounding factors thus call for a sufficient 
sample size in a GWAS in order to ensure a reliable discovery of real disease-related 
genetic variants. Therefore, a trade-off between cost and study power occurs in GWAS 
which may impede discovery of causal genetic variants in these studies. These challenges 
are commonly encountered in GWAS that adopts a one-stage design, where all genetic 
markers are genotyped in a case-control cohort and the p-value of each SNP is calculated 
by univariate tests. Given the prohibitive costs of such large scale genotyping, many 
researchers have adopted multi-stage approach in conducting GWAS. 
In this multi-stage approach, a small-scale GWAS is first conducted in a few 
hundreds of cases and control subjects. Subsequently, each SNP is tested using univariate 
tests with a nominal cut-off threshold for its p-value. While the liberal cut-off threshold 
of p-value ensures that almost all true-positive SNPs are included for further screening in 
later stages, many more false-positive signals may be included. In the second or probably 
third stage of the experiments, candidate SNPs selected from the first stage are genotyped 
in larger samples of case-control cohorts and their significance are tested under a more 
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stringent condition (i.e., the cut-off threshold of p-value should be much lower). 
Compared to false-positive signals that pass a test by random, true-positive signals are 
likely to pass the test once again with a higher probability. Thus, a multi-stage approach 
allows the interrogation of the whole genome in a smaller set of samples, preferably with 
enriched phenotypes, to discover candidate SNPs using less stringent test for significance. 
This is followed by the validation of these signals in an expanded sample size using a 
more stringent test, thereby reducing the cost of genotyping without necessarily losing 
the power to detect novel SNPs. Figure 1.2 elaborates the general principles of multi-
stage approach used in a GWA study. 
In a multi-stage GWAS, one issue relates to the estimation of the number of SNPs 
to be genotyped and the amount of samples to be tested in each stage. In the first stage of 
the experiment, Illumina and Affymetrix microarrays which typically carry 30-100K 
SNPs with or without CNVs are used to genotype one single sample. The costs of these 
chips are in the region of thousands of US dollars. In the second stage, tailor-made 
microarrays carrying 20-40 SNPs are typically used to genotype one person with the 
average cost of each SNP at one to a few US dollars depending on the technology (Skol 
et al. 2007). While the costs of these technologies continue to fall, the estimated cost 
ratios are in the range of 15-20 times, when we compare the cost per genotype in stage 1 
using SNP array and that in stage 2 using high-throughput genotyping technologies 
(Wang et al. 2006). Several experts have discussed the optimal design of a two-stage 
approach taking into consideration these cost ratios (Wang et al. 2006; Skol et al. 2007). 
It has been suggested that i f researchers decide not to genotype all the SNPs with nominal 
significance in stage 1, they should increase the marker density around the regions of 
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candidate SNPs that pass through this stage since many fixed SNP arrays only cover a 
standard set of SNPs (Wang et al. 2006). It has also been recommended that the 
difference in sample size for each stage of the experiment should be relatively small. 
Given the high cost of the SNP array and the relatively low cost of the genotyping 
individual SNP, this multi-stage approach may help to reduce the total cost without 
compromising the study power. In my study, I have adopted this two-stage approach with 
same number of samples in each of the two stages for my analysis. The experiment 
design wi l l be elaborated in Chapter 2. 
Sample size Numtver of SNPs 
G«n.oty(>e full set of SNPs in 
Stage 1 f 1 \ 7 relatively small population at 
j \ \ I lit>eral p value 
” / \ \ I Screen second, larger 
gx 2 I \ \ I population at more stringent 
I \ \ I i>-value 
4- L ^ \ j Optional third stage for 
Stage 3 increased stringency 
Figure 1.2: Overview of multistage approach for genome-wide association studies. 
Adapted from Hirschhorn and Daly, 2005 (Hirschhorn and Daly 2005). 
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1.3. Overview of statistical approaches in association studies 
1.3.1. Preliminary analyses 
In these association studies, preliminary analyses are critically important for 
quality control of data to ensure validity of the results. These include Pearson's chi-
square test and Fisher's exact test for Hardy-Weinberg equilibrium (HWE), imputation 
techniques for reducing missing rate of genotypes and measurement of linkage 
disequilibrium for selection of tag SNPs (Balding 2006). 
1.3.1.1. Hardy—Weinberg equilibrium testing 
In a case-control association study, a Pearson's chi-square test or a Fisher's exact 
test is firstly applied to the control subjects to check whether the population from which 
the controls were chosen is in Hardy-Weinberg equilibrium (HWE). I f the population 
frequency of allele A (major allele) is p, that of the other allele a (minor allele) is g = 1-p. 
The population is considered to be in HWE (Lewis 2002; Balding 2006) i f the following 
conditions hold: (1) There is no population stratification due to migration within the 
population (i.e., no exchange of alleles between different populations); (2) There is no 
selection pressure which influences allele frequency for any traits; (3) The size of 
population is large enough. Consequently, the three possible genotypic frequencies 
should be as follows: f(AA)=p^, f(Aa)=2p^, To test whether the population 
deviates from Hardy-Weinberg equilibrium, Pearson's chi-square test and Fisher's exact 
test are often applied. Suppose that the frequency of major allele A is and that of minor 
allele a is ^ = 1-p; the observed number of A A carriers is d, that of Aa carriers is e and 
10 
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that o f aa carriers i s / ; the total number of observed controls is n = d+e+f. p is calculated 
by the following equation: 
p = (2d+e) / (2d+2e+2J) 
The expected number of A A carriers, Aa carriers and aa carriers should be np:, 2npq and 
nq2. In terms of Pearson's chi-square test, we calculate the following value: 
义 F ^ 
(Obs(AA) - Exp{AA)f {Obs{Aa) - Exp{Aa)f {Obs{aa) - Exp{aa)f 
= 1 1 
Exp{AA) Exp(Aa) Exp{aa) 
{d-np'Y {e-2npqf { f - n q ' f 
= ； 1 1 2 
np 2npq nq 
The degree of freedom is 1. For any value below 3.84 (i.e., the 5% significant level for 
1 degree o f freedom chi-square test), the population from which the controls are collected 
w i l l be considered to be in HWE with a type I error of 0.05. To the contrary, a / ^ value 
bigger than 3.84 implies that the population does not fol low HWE which may be due to 
the fol lowing reasons (Lewis 2002): (1) random chance: the significance level is 95% and 
thus type I error is 5%; (2) genotyping problems: certain genotypes may have too many 
missing values; (3) heterogeneous population: the population from which the controls are 
collected has subclasses of populations, i.e. it is a mixture of different populations. 
Since Pearson's chi-square test is only an estimation, when the cell counts for A A 
or aa genotype are too small (Balding 2006), Fisher's exact test should be applied to test 
for deviation o f HWE for the population, described as below. 
Given the major allele A, the conditional probability of genotype Aa is (Emigh 
1980): 
11 
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/ \ n 
In 
Where p is the frequency of major allele A and q = I-p is that of minor allele; d, e, f are 
the observed number of A A carriers, Aa carriers and aa carriers respectively; n = d+e+f 
/ \ n 
is the total number of observed controls; is a multinomial coefficient that equals 
” I r « ^ 
to . (We may imagine that there are • possible arrangements for Aa 
d\e\f\ {d,e,f J 
f In \ 
genotype and possible arrangements for the alleles, as supposed in Wigginton 
\?-d + e) 
et al., 2005 (Wigginton et al. 2005).) Theoretically, a two-sided HWE test can be thus 
realized by computing the probability of observing a contingency table that is no more 
likely to appear than the table being evaluated, conditioning on the observed minor allele 
count Ha (Wigginton et al. 2005): 
Phwe = J^P(〜a = … 仏 , y satisfies thaX = e’| n, n^) < p(n 如 = e \ n , n^) 
e' 
In summary, HWE test is often applied before the major process of an association 
study to control data quality, by which loci with low quality (i.e., at a significant level 
less than 10"^  or would be disposed of (Balding 2006). 
1.3.1.2. Inference of missing genotype data 
The major aim of inference of missing genotype data is to retain most genotypes 
before an association study is analysed. Although there are genotyping errors and missing 
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values for certain SNPs, the bulk of the genotypes contain useful information which 
allows researchers to apply various techniques to infer the missing values in order to 
maximize the genotypic information and to limit the amount of biased information. 
One method for inference of missing genotypes is to infer missing genotypes of a 
sample from other observed neighboring genotypes of the same sample. Commonly used 
methods include maximum-likelihood estimate (MLE), by which the missing value is 
estimated to maximize the probability of other observed data (Balding 2006). Another 
method is to infer missing genotypes of a sample based on observed values of the same 
SNP, provided that other samples may probably have similar genotypes within the cohort. 
In the so-called 'hot-deck' method, the missing genotype is inferred from another sample 
that has matching genotypes at neighboring loci (Twisk and de Vente 2002; Barzi and 
Woodward 2004). In the regression-based imputation technique, the missing genotype is 
imputed based on the genotypes at neighboring loci of all the other samples (Souverein et 
al. 2006). Of note, it is preferable to carry out imputation for cases and controls 
separately since these populations are different in their phenotypes and thus, imputation 
based on all samples may generate unexpected biases and thus unreliable results (Balding 
2006). 
In my analysis of the case-control association study, imputation was carried out 
by random forests. Missing genotypes of each sample were imputed based on existent 
genotypes of other samples. The detailed procedure of imputation wi l l be discussed in 
Section 1.4.2. 
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1.3.1.3. SNP tagging 
Linkage disequilibrium (LD) is an essential concept that is closely related to SNP 
tagging, which indicates the degree of association between alleles at two loci on the same 
gene. I f we assume that two loci A and B have two alleles A/a and B/b respectively (i.e., 
a major allele and a minor allele), and the frequency of each possible haplotype is f (AB), 
f(Ab), f(aB) and f(ab). The frequency of each individual allele can be easily estimated by 
the frequencies of four possible haplotypes as f (A) = f(AB)+f(Ab), f(a) = f(aB)+f(ab), f(B) 
= f (AB)+ f (aB) and f(b) = f(Ab)+f(ab). I f the alleles at loci A and B are transmitted to the 
next generation in a completely independent way, the value D = f (AB)- f (A)* f (B) should 
be equal to zero; otherwise, the alleles at loci A and B are in LD. However, i f the 
frequency of any allele (f(A)/f(a)/f(B)/f(b)) is zero or one, then D may become 
unobservable. Thus, most researchers use D '一a normalized form of D—to estimate the 
degree o f LD between alleles at a pair of loci: 
' 丄 , D ^ O 
jy= < ^max 
— , D < 0 
lAnin 
Where D^ax = max(f(A)*f(b), f(a)*f(B)) and D,„i„ = min(f(A)*f(B), f(a)*f(b)). Another 
measurement of LD is r^, which is the correlation coefficient between loci A and B and 
D -) 
denoted as r = , i = . To facilitate the calculation of D’ and r , some 
^ f { A ) f { a ) f { B ) m 
softwares have been developed to generate not only pairwise LD status between two loci 
but also the overall LD status over a region of chromosomes, such as haploview (Barrett 
et al. 2005). By detecting the LD over the whole human genome, it is found that much of 
the human genome is organized by LD blocks. These findings suggest that there is almost 
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no recombination within the LD blocks but frequent recombination may occur at 
boundaries of different LD blocks (Balding 2006). Such arrangements have made it 
feasible to select representative SNPs within LD blocks as genetic markers in association 
studies. This process is called "SNP tagging" and is widely adopted in GWAS. Tag SNPs 
are commonly determined by computation r^ value of pairs of SNPs or other complex 
techniques. Alternatively, these tag SNPs for a specific gene can be selected from the 
public database of the International HapMap Project (2005). There are two major benefits 
for tag SNP selection in a GWAS (Balding 2006). Firstly, this process can reduce the cost 
of the study without compromising the power of study. Moreover, SNPs in LD can be 
selected based on their genotyping quality (i.e., percentage of missing genotypes, error 
rate of genotyping, etc.). Secondly, this selection process would reduce the number of 
SNPs and thus complexity of statistical analysis with less random noise and increased 
power. Thus, the use of tag SNPs can filter the closely correlated SNPs and those with 
low genotyping quality. These approaches wi l l help to retain the most useful information 
in the dataset to increase the performance of the analysis for discovery. 
1.3.2. Single-point and multipoint tests for association 
Usually, single-SNP analyses begin with a contingency table, irrespective of the 
genetic model. Common methods based on a contingency table to detect association 
between individual SNPs and phenotypes include Pearson's chi-square test and Fisher's 
exact test (Lewis 2002; L i 2008). As discussed in Section 1.3.1.1, Pearson's chi-square 
test measures the difference between observed value and expected value of each cell in 
15 
CHAPTER 1. Introduction 
the contingency table as following, assuming that a single SNP has no model assumptions 
(i.e., a general genetic model or a genotypic model, as described in Table 1.3(a)): 
,=i L 丨 
The number of items in this equation is determined by the number of cell counts in the 
contingency table. In most cases, Pearson's chi-square test can be used for single-SNP 
analyses. However, when one cell has less than five elements, Fisher's exact test is more 
robust than Pearson's chi-square test and thus preferred. 
Before we carry out single-SNP analyses in an association study, it is necessary to 
assume a specific model for individual SNPs. There are five common models which 
include a general genetic model/genotypic model (Table 1.3(a)), a dominant model 
(Table 1.3(b))，a recessive model (Table 1.3(c)), a multiplicative model/allelic model 
(Table 1.3(d)) and an additive model (Table 1.3(e)). Each model corresponds to a slightly 
different contingency table. 
The most generic model of a SNP is a genotypic model. In this model, each 
possible genotype of two alleles at a locus has a different categorical value for both cases 
and controls; in other words, the three possible genotypes AA, AB and BB are not 
comparable to each other and there is no order for these genotypes. The corresponding 
contingency table of this model is a 2x3 table. In brief, this model is commonly adopted 
when the genotype model of a SNP cannot be determined specifically. Under this 
condition, it is safer to assume a genotypic model for the SNP than to apply other 
genotype models. 
The second model is a dominant model that allele B is the risk-conferring allele 
and any genotype with an allele B (i.e., AB and BB) is regarded as a risk-conferring type. 
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The size of its contingency table is 2x2 and the statistical test is carried on A A versus AB 
plus BB. Compared to the dominant model, the recessive model assumes that allele B is 
the risk-conferring allele and only BB genotype increases the risk. The size of its 
contingency table is 2x2 and the statistical test is carried on BB versus A A plus AB. The 
fourth model is an allelic model with an assumption that each allele of the SNP affects 
the phenotype independently, which means that i f the risk of heterozygote AB is r, the 
risk of homozygote BB wi l l be r^. The advantage of this model is that the number of 
observed samples is doubled, whereas one drawback of the model is that the genotype-
specific information is ignored. The last model is an additive model where the dose effect 
of a SNP is considered. That means the degree or intensity of association between a SNP 
and a phenotype depends on the minor allele B in an additive way. In other words, i f the 
risk of genotype AB is r, then the risk of genotype BB is 2r. 
Apart from the Pearson's chi-square test Cochran-Armitage test is frequently used 
in these analyses. As indicated in Figure 1.3, a least-squares fitting line is used for the 
three types of genotypes and the null hypothesis that the fitting line has a zero slope is 
checked by this test. Cochran-Armitage test is considered a conservative and robust test 
which is not influenced by HWE status of the dataset (Balding 2006). 
There is no consensus on how to decide the best model for each SNP among the 
five possible models. I f previous studies support certain types of genetic models, it is 
reasonable to adopt that model in the association analysis for a particular SNP. I f prior 
knowledge is lacking, it is more reliable to carry out statistical tests based on each 
possible model and then choose the one with the maximum likelihood value (Zheng et al. 
2008; Alcina et al. 2009). 
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The same contingency table for each genetic model can also be analyzed by 
logistic regression (Lewis 2002). Compared to Pearson's chi-square test and Fisher's 
exact test, logistic regression has additional advantages. In regression models, additional 
continuous traits such as age of onset, sex and population information can be included as 
covariates to adjust the effects of SNPs and estimate SNP-environment interactions can 
be investigated. I f the coefficient of a SNP in this model no longer remains significant 
after adjusting for covariates, it may be concluded that the effects of the SNP on a 
phenotype may be mediated or confounded by these covariates and may not serve as an 
independent factor of the phenotype. For most complex diseases, important clinical traits 
such as age, sex and population information should be included to increase the validity 
and reliability of these association studies (Zheng et al. 2008). 
An extension of single-point logistic regression is that multiple SNPs can be 
analyzed in a common regression model. Due to interference of other SNPs, the effects of 
every SNP may be attenuated and its coefficient becomes insignificant. However, some 
SNPs may remain significant despite this joint analysis which indicates that they may 
influence the phenotype in an independent way. Apart from logistic regression, there are 
other techniques which can be used to analyze multiple SNPs in a model, such as 
haplotype-based analyses and random forests (RF). These methods take into account the 
joint effects of different SNPs and are increasingly applied in many association studies. 
Details of random forests wi l l be introduced in Section 1.4.2. 
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(a) Full genotype table for a general genetic model 
I A乂 AB BB 
Cases a b c 
_ Controls | (i | e | / 
(b) Dominant model: allele B increases risk 
A A AB+BB 
Cases a b+c 
Controls d e+f 
(c) Recessive model: two copies of allele B required for increased risk 
A A + A B BB 
Cases a+b c 
Controls d+e f 
(d) Multiplicative model: r-fold increased risk for AB, r increased risk for BB. 
Analyzed by allele, not by genotype 
A I B — 
Cases 2a+b 2c+b 
— Controls 2d+e 2f—e ~ 
(e) Additive model: r-fold increased risk for AB, 2r increased risk for BB. Genotype 
analyzed by Armitage's test for trend 
A A I AB BB 
Cases a ^ c 
Controls \ d \ e I / 
Table 1.2: Overview of single-SNP analyses. Adapted from Lewis, 2002 (Lewis 2002). 
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Figure 1.3: Cochran-Armitage test applied in single-SNP association. Adapted from 
Balding, 2006 (Balding 2006). 
1.4. Other relevant methods employed in this study 
1.4.1. Self-Organizing Maps (SOM) with further classification by K-means 
clustering 
Self-organizing map (SOM) is an unsupervised neural network method which is 
widely used in various dimension-reduction tasks (Vesanto et al. 2000; Wang et al. 2002; 
Sampsa et al. 2003; Wolf-Yadlin et al. 2006). Several studies have reported that SOM has 
a better performance than common hierarchical-clustering method in terms of noise 
tolerance, speed and robustness of results (Sampsa et al. 2003). Generally, SOM 
transforms high-dimensional input data into a lower dimensional space and generates a 
two-dimensional map for data display. 
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A SOM is composed of multiple neurons; each neuron is represented as a map 
unit in SOM by a d-dimensional reference vector m = (n”’ m〗’ m j , which has the 
same dimension as samples. I f we suppose that the Euclidian distance between a sample 
vector X and a neuron is ||x-mi||, then the best matching unit of x (BMU) is the nearest 
neuron c to x, that is, ||x-nic|| = min(||x-mi||). The SOM is trained for multiple iterations. 
After the initial positions of neurons are arbitrarily selected, the positions of neurons are 
updated based on the distance between the input sample vector x and themselves. In other 
words, once x enters into the SOM, we search for its best matching unit (i.e., nic) and a 
small set of neighboring neurons including nic wi l l change their current position to 
another one that is closer to x (Figure 1.4). By repeatedly entering new sample vectors 
into the SOM, it is expected that all the neurons wi l l be arranged in their optimized 
position and at that point, the SOM is representative of the original structure of the input 
sample set. The update of neurons' position is based on the following equation: 
m, (/ + !) = m. (r) + a{t) • K 丨 一 m, (/)] 
Where mi(t) and mi(t+l) represent the positions of neuron i at iteration t and t+1 
respectively, x(t) is the sample vector entering into SOM at iteration t, a(t) is the applied 
learning rate and hci( t) is the neighborhood function at iteration t, which is used to define 
the affected region by input sample x in the SOM. There are different types of learning 
rate and neighborhood functions. For neighborhood function hci( t ) , the gaussian type is 
more favorable than other types because it is biologically meaningful (Sampsa et al. 
2003). Another version of SOM algorithm is called "batch training" (Vesanto et al. 2000; 
Sampsa et al. 2003). Compared with the previous SOM algorithm that trains SOM 
incrementally, batch training adjusts nii(t) for all neurons simultaneously based on current 
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positions of all the samples as follows (Vesanto et al. 2000)，where n is the number of 
samples, neuron c is the B M U of sample j : 
+ = 
./=i 
In this way, positions of neurons are changed in parallel. It has been reported that batch 
training works faster than incremental training and assures convergence of neurons' 
positions more readily (Sampsa et al. 2003). 
In summary, the key goal of this training procedure is to minimize the overall 
error E(t) by optimizing positions of neighboring neurons based on input samples: 
/=i 
Where N is the number of neurons. Figure 1.5 well demonstrates the overall training 
procedure of SOM. During each iteration, the distance between the new input sample and 
each neuron is calculated in order to determine the winner neuron (i.e., the BMU, as 
mentioned above). Thus, neighboring neurons around the winner neuron wi l l update their 
current position, which to certain extent, is determined by their individual neighborhood 
function hd. Note that both reference vector of neurons and sample vectors are in 4-
dimension. 
Since nearly all samples can be classified into a class based on their nearest 
neuron in the SOM, we may simply calculate the distance between an input sample and 
every neuron, find out its B M U and determine its initial class. However, there is still 
another problem that the number of neurons in SOM might be too large; in other words, it 
is necessary to introduce other clustering methods to further refine the classification 
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result generated by SOM (Figure 1.6). Since the secondary classification is applied to a 
set of refined prototypes or "local averages" rather than on sample vectors directly, this 
classification technique has two major advantages (Vesanto and Alhoniemi 2000). Firstly, 
the computational complexity of two-level clustering is reduced and secondly, this 2-
stage approach is more robust than single-level clustering in reducing noise or outlier 
samples. The applications of this concept have been elaborated in several previous 
studies (Vesanto and Alhoniemi 2000; Wang et al. 2002). In practice, this systematic 
approach helps to reduce the number of subgroups within input samples that are 
originally represented by neurons in the SOM, giving rise to limited subgroups with 
distinctive features, such as classes of genes with similar expression patterns (Wang et al. 
2002). 
As indicated in Figure 1.6, in my analysis, I firstly applied SOM to classify 
sample vectors into different two-dimensional prototypes represented by neurons on the 
SOM grid and then classified the reference vectors of neurons into several classes. For 
the secondary abstraction level, both hierarchical clustering and K-means clustering can 
be used to further refine classification of reference vectors of neurons. In my study, I 
applied K-means clustering which belongs to a family of partitive clustering algorithms 
that determine the best partition manner to classify a whole set of samples into K clusters. 
The number of predefined clusters is determined by users; after K cluster centers are 
chosen, samples are classified into the K clusters based on the distance between each 
cluster center and themselves. After this preliminary classification step, the original 
positions of cluster centers wil l be updated according to the members of their individual 
C 2 
clusters. This procedure wil l be repeated until the overall error E = H x-C/^ is 
k=\ xeO^. 
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minimized locally (C: the number of clusters; Ck： center of cluster k). Since the number of 
clusters in K-means clustering is arbitrarily defined by the users before the training step, I 
introduced another method to automatically choose the best number of clusters (Wang et 
al. 2002). Firstly, the partitioning procedure is run repeatedly for several different values 
of K. Then, I used Davies-Bouldin validity index (DB index) to select the best 
partitioning result: 
Z ) 忍 = 丄 : f > a x 卜 瓜 ) + 民 ( 叫 _ 
c h 1 心 . ( a , a ) J 
Where Sc(Qk) is the average within-cluster distance and dcc(Qk, Qi) is the distance 
between cluster centers. More detailed description of Davies-Bouldin validity index can 
be found in the paper by Vesanto and Alhoniemi (Vesanto and Alhoniemi 2000). By 
choosing the partition with a minimum DB index, I can eventually determine the most 
appropriate number of clusters for classification of samples. 
The classification result of SOM can be directly visualized by U-matrix and 
component planes (Figure 1.7) (Sampsa et al. 2003). U-matrix is defined as a 
combination of original neurons in SOM and additional distance units between pairs of 
neighboring neurons. The U-matrix for hexagonal type of SOM is detailed in figure 
1.7(a), where each pair of neighboring neurons X and Y on the SOM grid share one 
common distance unit d(X, Y) and the distance directly determines the color of this 
distance unit. Component planes (Figure 1.7(b)) show the individual dimension of 
reference vectors of neurons. Figure 1.7(b) provides an explicit example of SOM 
visualization. The top-left sub-graph shows the U-matrix in a study on gene expression 
variation among different cancer cell lines. The two circles indicate two possible clusters 
bordered by light grey units. The region within each cluster is nearly black or dark grey, 
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which indicates that the adjacent units within each cluster are closer to each other than to 
other units outside the cluster. The distinctive expression pattern of the genes within each 
cluster is also detectable in individual component planes for different cancer cell lines. 
Genes in the upper circle are overexpressed in ZR-75-1, Hs578T and BT-474 and 
underexpressed in MDA-436, whereas genes in the lower circle are overexpressed in BT-
474 and underexpressed in the other three cell lines. Since the actual size of U-matrix 
composed of neurons and distance units is larger than each component plane composed 
of purely neurons, the size of actual clusters is smaller than their size in U-matrix. By 
combining U-matrix and component planes, users are able to investigate distinct features 
of each cluster and connect the classification results with possible biological meanings. 
W ' ' ： - - / 
！ -—I：：--- / 
“ i TBMU 1 ^ — -： ^ 
I \ 1 1 
Figure 1.4: The process of updating the positions of neurons. Black nodes represent 
original positions of neurons, whereas grey nodes are updated positions of neurons. X is 
the sample vector that enters into the SOM. Adapted from Vesanto, 2000 (Vesanto et al. 
2000). 
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Figure 1.5: The overall training procedure of SOM. Adapted from Sampa, 2003 (Sampsa 
et al. 2003). 
Abstraction level 1 Abstraction level 2 
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Figure 1.6: Two-level data classification by SOM combined with other clustering 
methods. Adapted from Vesanto, 2000 (Vesanto and Alhoniemi 2000). 
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Figure 1.7: Visualization of SOM. (a) definition of U-matrix; (b) An example of SOM 
visualization. Two circles in the U-matrix indicate possible clusters. The other four 
graphs are component planes in four different cancer cell lines ZR-75-1, Hs578T, MDA-
436 and BT-474. The circle in the component plane Hs578T indicates a group of 
overexpressed genes. Adapted from Sampsa, 2003 (Sampsa et al. 2003). 
1.4.2. Random forests 
Random forests are nonparametric model based on decision trees applied for 
various tasks including classification, feature selection etc (Bureau et al. 2005). Random 
forests are composed of hundreds or thousands of classification trees and each tree serves 
as a weak learner and contributes to a small portion of overall classification result by 
voting scheme. This technique is highly versatile since it can serve multiple purposes, 
such as classification of unknown samples, estimation of variable importance (i.e., 
feature selection), imputation of missing values, detection of outliers, epistasis study in 
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genetic analysis etc. Accordingly, random forests are increasingly accepted by biologists 
and geneticists as a useful tool to screen for disease-related candidate SNPs (Lunetta et al. 
2004; Glaser et al. 2007; Meng et al. 2007; Schwarz et al. 2007; Sun et al. 2007)，gene-
gene interactions (Bureau et al. 2005) and microarray-based detection of cancer-specific 
marker genes (Jiang et al. 2004; Diaz-Uriarte and Alvarez de Andres 2006). 
Random forests make use of bootstrapping techniques and modified decision-tree 
based methods to construct a huge set of classification trees. The training set is used to 
create each classification tree with replacement, indicating that duplicate samples might 
be probably sampled for multiple times during the training process. As a result, some 
other samples must be left and are termed "out-of-bag" (OOB) samples. These samples 
are used to estimate unbiased classification error or overall performance of random 
forests. They can also be used to compute the importance index of each variable in the 
model like candidate SNPs. 
Random forests only randomly select a smaller set of variables and use the most 
appropriate one to generate child branches for each node of a classification tree. This 
classification tree is not to be pruned but reaches its maximum size during the training 
process. The following briefly describe on how to use random forests to estimate 
importance index of variables and impute missing values (Bureau et al. 2005). 
Suppose that input samples belong to two distinct classes; X j represents the 
variable vector for sample i; tjj is an indicator that takes value one when sample i belongs 
to the set of OOB samples for tree j and zero otherwise; 5j(Xi, y) is an indication function 
that takes value one when sample i is correctly predicted in class y by tree j ; otherwise it 
takes value zero: 
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^ ^ ^ ^ ^ ^ ^classy 
•‘ ‘， [O, X丨茫 class y 
Empirically, around one-third of samples are left during the training process for one 
classification tree (Leo 2001). In other words, each sample may serve as an OOB sample 
over one-third of the trees. For the OOB sample, we enter it through each of the trees (i.e., 
around 33% of all trees) to get a "vote" for its possible class and eventually determine its 
class based on the largest amount of votes by the trees. The margin o f votes mg(Xi, y) is 
defined as the difference between the number of correct predictions and that of wrong 
predictions by the random forests: 
上• ./=1 1 i ./=! 
T 
Where T]=工,"and T is the number of classification trees in the random forests; y is the 
7=1 . 
correct class of sample i and y is the wrong class of sample i. The margin of votes mg(Xi, 
y) indicates the confidence of prediction (Bureau et al. 2005) and appears to be large i f 
most trees vote for class y compared with class y . When we try to compute the 
importance index of variable A, we firstly take a random permutation on the values of A 
for OOB samples o f all the trees. (Note that since each input sample may serve as an 
OOB sample in different trees and permutation is carried out for each tree individually, it 
may probably have different permutated value on variable A for distinct trees.). Then, we 
calculate the average change of margin of vote as the importance index of variable A: 
, y) - mg{xf,少)： 
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Where N is the number of samples, y is the correct class of sample I, Xj and XF are the 
variable vector of sample i before/after the value of A is randomly permuted. This index 
indicates the influence of variable A on classification performance of random forests. 
In a genetic association study, i f a genotype is strongly associated with the 
consequential phenotype, its importance index should be ranked among the top ones. 
Otherwise, the change of its value over OOB samples would merely influence the 
classification result slightly and thus, it would probably have a relatively small value of 
this parameter. The z-score of random forests for variable A is the importance index of A 
divided by its standard error. It is also assigned with a significance level assuming a 
normal distribution. 
Missing values of samples can be imputed by random forests based on proximity 
of each pair of samples (Qi et al. 2005). After a tree is created, both the samples for 
training and the rest OOB samples are run under the tree. As a result, i f one pair of 
samples falls in the same terminal leaf node of the tree, we increase the level of their 
pairwise proximity by one. By averaging this pairwise proximity over all the trees, we 
eventually obtain the proximity matrix for all the samples. This feature enables us to 
estimate the missing values of sample i based on other samples that have non-missing 
values for the same variables. For the missing genotype of a sample, we replace it based 
on other non-missing genotypes for the same SNP. In details, i f sample i has a missing 
genotype for SNP A with three types of possible genotypes AA/Aa/aa and the pairwise 
proximity between sample i and any other sample j is prox(i, j ) , the imputed genotype of 
sample i for SNP A wi l l be Ge , : 
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从 if Y.prox(i,j) = max( Y^prox(i,k、, 
Gej=AA Gef=AA Get=Aa Gej'=aa 
Gef = j Aa, if P而(“众）=max( J ] prox(i, J), ^ prox(i, k), Yj prox{i,/)) 
aei}=Aa Gej=AA Ge^ =Aa Gef=aa 
aajf ] ^p rox ( / , / ) = max( Y^proxiiJ、、 
Gef=aa Genj=AA Ge-^=Aa Gef=aa 
In summary, the imputed genotype of sample i for SNP A is mostly influenced by the 
samples in close proximity to sample i with non-missing genotypes for SNP A. 
1.5. Main objectives of this study 
In this two-stage association study, I used a hybrid method to improve the 
classification o f samples and to apply multiple methods to discover SNPs associated with 
type 2 diabetes. 
1. I first used SOM to generate pairs of sample sets with similar distribution on clinical 
traits. 
2. I then used two different 2-stage approaches to discover these diseases-associated 
SNPs. In the first instance, I used random forests and chi-square test in the first and 
second stage respectively. I then compared this approach with another 2-stage 
approach using only chi-square test. 
3. I also examined the joint effects of the top selected SNPs and discussed their possible 
biological functions or influence by referring to previous studies. 
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CHAPTER 2. Materials and methods 
2.1. Study cohort 
In this analysis, I used a database consisting of 776 samples (485 type 2 diabetic 
patients and 291 control subjects). Briefly, all cases were Chinese in ethnicity and had 
type 2 diabetes with a positive family history of diabetes. A l l control subjects were either 
participants of a health screening study or volunteers with no past medical history. A l l 
subjects underwent a comprehensive assessment for cardio-metabolic risk including a 75 
gram oral glucose tolerance test (Table 2.1). A total of 16 clinical traits were available in 
these subjects. We selected 560 candidate genes implicated in type 2 diabetes (islet 
development, insulin synthesis and secretion, insulin action, lipid metabolism and 
neurohormonal pathways), 7 newly discovered type 2 diabetes genes and a panel of novel 
SNPs found positive in 2 Caucasian cohorts in a GWAS using tailor-made microarray 
supplied by ROCHE. A total of 1895 SNPs were genotyped in these subjects. 
The original database was split into two independent sample sets for the first stage 
and second stage of the analysis respectively. For quality control, 42 samples with more 
than 10% missing values among their genotypes were discarded after treatment by SOM 
and K-means clustering to ensure at least a 90% call rate for all analyzed samples. 
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Clinical traits Type 2 diabetes Control subjects 
(n=485) (n=291) 
Male sex (n, %) 178 (36,8%) 107 (36.8%) 
Age (years) 39.2 士 8.4 39.4 士 10.9 
Age of onset (years) 31.2 士 5.9 NA 
Disease duration (years) 8.1 士 7.5 NA 
Fasting plasma glucose (mmol/L) 8.8 士 3.4 4.8 土 0.4 
Fasting triglyceride (mmol/L) 1.9 士 2.4 1.6 士 0.4 
Total cholesterol (mmol/L) 5.3 士 1.2 4.8 士 0.8 
HDL- cholesterol (mmol/L) 1.3 士 0.4 1.6 士 0.4 
LDL- cholesterol (mmol/L) 3.2 士 0.9 2.9 士 0.7 
Metabolic syndrome (n, %) 253 (52.4%) 7 (2.6%) 
Body mass index (kg/m^) 25.8 士 4.6 22.3 士 3.0 
Waist circumference (cm) 84.1 士 11.6 74.4 士 9.2 
Hip circumference (cm) 97.5 土 8.8 92.7 士 5.7 
Systolic blood pressure (mmHg) 124.7 士 18.0 112.3 士 13.3 
Diastolic blood pressure (mniHg) 74.7 士 10.3 69.4 士 10.1 
Fasting insulin ( lU/L) NA 45.2 士 42.1 
Table 2.1: Clinical and biochemical profiles of young type 2 diabetic patients and control 
subjects used in the analysis for SNP discovery. A l l clinical traits except male sex & 
metabolic syndrome percentage are shown in the form of mean value 士 standard error. 
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2.2. Study design 
2.2.1. Construction of sample sets for each stage by SOM and K-means clustering 
In this two-stage analysis, we required two independent sample sets to perform 
the genetic association analysis in each of the two stages. In many of these GWAS, 
signals discovered in the first stage of experiment often failed to replicate in independent 
sample sets, in part due to heterogeneity of subphenotypes. Thus, to increase the 
possibility of replicating these signals, the distribution of phenotypes in the first (training) 
and second (testing) sample sets should be similar. Therefore, we introduced SOM as a 
mature classifier in our study followed by further classification of reference vectors of 
neurons by the K-means clustering technique. This hybrid method enables us to cluster 
the cases and controls respectively into several sub-groups. Based on these classification 
results, we created ten pairs of independent sample sets for the first stage and the second 
stage respectively in our study. The clustering procedure was carried out using the SOM 
Toolbox for Matlab® 5 (Vesanto et al. 2000) and other embedded functions in Matlab® 
2007a. The cases and controls were treated as two individual groups. Here, I described 
the treatment for controls only (with 14 clinical traits without age of onset of disease and 
disease duration) but the same procedure was applied to the cases (with 16 clinical traits 
plus age of onset and disease duration). 
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Figure 2.1: Framework of sample classification using SOM and the K-means clustering 
and creation of pairs of independent sample sets. Cases and control subjects were 
clustered separately using SOM and the K-means clustering. Cases/control subjects 
within each subclass were randomly distributed into two sample sets for the first and 
second stage of the analysis respectively. By repeating the above procedure, ten pairs of 
sample sets were created. Each pair of sample sets individually constitutes the original 
dataset consisting of 776 samples. 
(1) Preprocessing of samples: the sixteen phenotypes of cases were read into Matlab® 
2007a. Then, every phenotype was normalized through a linear transformation to give a 
variance of one. Since variables with a large value range (e.g. from 0 to 1000) which may 
have dominant influence in classification over variables with a lower range of value (e.g. 
from 0 to 1), this normalization procedure was essential in order to improve the 
performance of the clustering procedure. 
(2) Training of SOM: a SOM was created for cases using standard procedures with 
generation of the corresponding U-matrix and component planes for all phenotypes. As 
discussed in Section 1.4.1, I used batch training algorithm to train the SOM for 
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phenotypes since this algorithm runs faster and achieves convergence more efficiently 
than using incremental training. 
(3) Detection of sample hits among Voronoi sets of neurons: Given a discrete set of 
points S and a point i in S, the Voronoi set V( i ) indicates a set of points consisting of all 
the points that were closer to i than to any other points in S. For this step, I examined the 
Voronoi sets of neurons to ensure that they all any cases. In other words, i f no cases fell 
into the Voronoi sets of certain neurons, they would not participate in the subsequent 
classification process by the K-means clustering method. 
(4) K-means clustering on the selected neurons: Only neurons with non-zero sample hits 
in their Voronoi sets participated in the K-means clustering process. The tentative range 
of the number o f clusters was [1，10]. The best number of clusters was determined by the 
Davies-Bouldin index (DB index), which should be the least value o f DB index. In this 
analysis, the most appropriate number of clusters was 9. K-means clustering was carried 
out for one hundred times iteratively to ensure consistent clustering result. To find out the 
cluster o f a case, I firstly searched for its B M U in SOM and then identified the cluster 
where the B M U was located. By this procedure, all cases were distributed into a cluster 
among the K clusters, assuming that K was the best number of clusters. This allows the 
generation o f the adjusted map of clusters on the original SOM. A l l neurons were 
clustered into K different classes with all neurons located within a cluster which took on 
a distinct color. Thus, the original SOM became a map consisting of nine colorful regions. 
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(5) Creation of two independent sample sets according to the clustering result: After the 
class of each case was determined through the last step, cases within each cluster were 
partitioned randomly and equally into two sets, one set belongs to the sample set for the 
first stage of association study and the other belongs to the sample set for the second 
stage of the study. 
Data from the control subjects were subjected to the same process (from step 1 to 
step 5) to generate a SOM with different clusters. Control subjects within each cluster 
were partitioned equally into two independent sample sets for the first stage and the 
second stage respectively. I repeated the same process in both cases and controls, each for 
ten times and thereby generated ten pairs of sample sets for each stage of the association 
study. This clustering procedure (from step 1 to 5) allows balanced distribution of the 
most dominant phenotypes in each case-control sample sets to increase the likelihood of 
replication of signals discovered in this 2-stage analysis. 
2.2.2. Stage 1 analysis by random forests 
As mentioned in the previous section, for each pair of created sample sets, one 
sample set was selected arbitrarily for the first stage and the other for the second stage of 
the analysis. Random forests serve as a tool for feature selection and were employed in 
the first stage to screen for candidate SNPs after data processing for quality control (QC). 
A total of 42 samples with SNP call rates below 0.9 were abandoned from the original 
database of 776 samples, i.e. all samples in the database had less than 10% of missing 
genotypes among 1895 SNPs. The final dataset for analysis comprised of 734 samples 
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(283 controls and 451 cases). These samples with low quality were detected and removed 
from the newly created ten pairs of case-control subsets. After these QC procedures, the 
samples were analyzed by random forests, using Random Forests, Version 5.1 (Breiman 
and Cutler 2004). 
(1) Imputation o f missing genotypes: Although samples with low data quality were 
removed before the training process of random forests, some of these samples contained 
missing genotypes. As discussed in Section 1.4.2，random forests have the ability to 
impute missing values by comparing the proximities between a sample with missing 
genotype for a SNP and others with available genotype for the same SNP. Firstly, 
missing genotypes for one SNP were imputed as categorical variables by the most 
frequent genotype for the SNP in question. Then, pairwise proximities between samples 
were computed by running them down each decision tree. The missing genotype was 
eventually estimated by other samples with available genotype for the same SNP, 
particularly influenced by those with higher proximity with the sample. Four relevant 
parameters in the imputation of missing genotypes include nprox, nrnn, missfill and 
mfixrep and their default setting is nprox = 1，nrnn = 25, missfill = 2 and mfixrep = 5. 
This setting indicated actual values o f pairwise proximity and was computed between 
each training sample and its 25 most proximate training samples. Once missing 
genotypes were imputed during a run, the proximity matrix was re-estimated based on the 
modified sample set in the next run. The running time for the same procedure was five. 
Other key parameters for overall training of random forests are briefly described in table 
2.2. 
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(2) Training of random forests: The modified sample set was used to create random 
forests. The amount of random forests was set as 2000 (i.e., jbt = 2000) according to 
Diaz-Uriarte (Diaz-Uriarte and Alvarez de Andres 2006). This number was sufficient and 
further increase was not likely to improve overall performance. The number of SNPs that 
were randomly tested for splitting a node of decision trees was 15% of the total number 
o f SNPs (i.e., mtryO = 0.15 * mdim, where mdim indicates the number of SNPs). Note 
that mtryO could be adjusted when mdim became quite small during the late iterations of 
training. Once 0.15 * mdim < 25, we set mtryO as 25. Since a sample set may contain 
unbalanced number of cases and controls, the performance of random forests may be 
influenced by the overweighted class of samples. This can be overcome by setting an 
additional weight for samples within each class (Chen et al. 2004). In our experiment, the 
weight for cases was the number of controls and that for controls, was the number of 
cases in a sample set. For instance, provided that a sample set contains a cases and b 
controls, the weight for cases is set as b and that for controls, set as a. By this adjustment, 
classification error for cases would be similar to that for controls and random forests were 
then more likely to achieve a stable and improved overall performance. The weight for 
each class is set by parameters jclasswt and classwt(i) in random forests; for the case 
QbovQjclasswH = 1, classwt(l) 二 a and classwt(2) = b, supposing controls were in class 1 
and cases were in class 2. 
(3) Selection of candidate SNPs: As discussed in Section 1.4.2, a classification error by 
random forests over OOB samples is generated after their training process. This value is a 
weighted average of classification errors on cases and controls respectively. Moreover, 
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each SNP wi l l obtain an adjusted z-score (i.e., importance index) and a p-value indicating 
its significance for measurement of its contributions to predication of sample classes. In 
our experiment, SNPs with positive importance index were retained in the sample set, 
whereas others with negative importance index were abandoned. This implies that SNPs 
with negative importance index are likely to reduce the performance of random forests 
and thus should be removed from the sample set. No samples were removed from the 
sample set. 
(4) Repeat step 2 and step 3 for ten times. After performing these steps, I compared the 
average classification error among the random forests generated in these ten iterations. 
The random forests with the least overall classification error were selected as the best 
random forests, whose sensitivity, specificity, PPV and FPV of classification of OOB 
samples were generated in parallel. Besides, the SNPs with significant importance index 
(i.e., p < 0.05) were chosen as candidate SNPs for the second stage of the association 
study. 
There were ten pairs of sample sets in each of the 2-stage analysis. In the first 
stage, ten lists of candidate SNPs were generated by random forests. Each of these 10 sets 
of candidate SNPs were analyzed using the Pearson's chi-square test or Fisher's exact 
test in the second stage. 
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Parameter Value Comments 
classwt(i) The weight for samples within class i. This parameter is only valid when 
jclasswt = 1. For our case-control study, c/a^^w^C'control") = a and 
= b, supposing there are a cases and b controls in a sample 
set. 
jbt 2000 The number of decision trees generated using random forests. 
jclasswt 1 Whether class weight is involved. When jclasswt = 1, a weight is set for 
samples within each class. When it takes zero, the same weight is 
considered for each class. 
mdim The number of SNPs. 
mfixrep 5 Time of iterations for imputation of missing genotypes. Every iteration 
contains a step for computation of proximity matrix and a step for data 
imputation. 
missfill 2 OR 0* Imputation of missing genotypes. Imputation is based on proximity matrix 
when missfill = 2 (only adopted in step 1); the function is turned o f f when 
missfill = 0. 
mtryO 0.15*mdim The number of SNPs that are randomly tested for splitting a node in a 
OR 25 decision tree. Note that when 0.15 * mdim < 25, mtryO is set as 25. 
nclass 2 The number of classes involved. For case-control studies, nclass = 2. 
nprox 1 Computation of pairwise proximities. Actual values of pairwise 
proximities are computed on training samples when nprox = 1. 
nrnn 25 The amount of pairwise proximities that are estimated for each sample. 
Each sample has 25 recorded values of pairwise proximity among its top 
25 proximate samples when nrnn = 25. 
ntrain The number of training samples. 
nrnn 25 The amount of pairwise proximities that are estimated for each sample. 
Each sample has 25 recorded values of pairwise proximity among its top 
25 proximate samples when nrnn = 25. 
Table 2.2: Key parameters that are adopted for training of random forests. Other irrelevant 
parameters are not recorded in this table. 
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2.2.3. Stage 2 analysis by chi-square test 
As mentioned in the previous section, a list of candidate SNPs were generated by 
random forests in the first stage. In the second stage, an allelic chi-square test was used to 
detect significant SNPs among the candidate ones generated from the first stage. Another 
independent sample set was used to carry out the association study in this stage. As 
discussed before, random forests are merely able to analyze datasets after missing 
genotypes are imputed, which helps to reserve most genotypic information in the datasets. 
However, chi-square test does not have the ability to impute missing genotypes and in 
practice, it is used to analyze datasets with incomplete content by simply ignoring the 
samples with missing genotypes. Thus, I applied allelic chi-square test in this sample set 
without imputing missing genotypes in the sample set. Moreover, as the two sample sets 
used in the first stage and the second stage have similar number of samples, we could 
foresee that when a chi-square test was earned out, only one or two cells in the 2x2 
contingency table might have less than five elements. Under this condition, we adopted 
Fisher's exact test instead of Pearson's chi-square test to compute p-value for 
significance level of candidate SNPs. 
Analysis by allelic chi-square test or Fisher's exact test in the second stage of the 
association study was implemented by PLINK (Version 1.04) (Purcell et al. 2007; Purcell 
2008). SNPs with significant p-value (i.e., p < 0.05) were considered candidate ones for 
future analysis. The same procedure was repeated for ten times in the ten pairs of samples 
sets to generate ten lists of candidate SNPs. The above two-stage approach is called 
"hybrid approach" (abbr., RF)，while the following two-stage approach done by purely 
chi-square test is abbreviated as chisq. 
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2.2.4. Two-stage genetic association study by chi-square test 
This section was finished in parallel with Section 2.2.2 (i.e., stage 1 analysis by 
random forests) and its flow chart is shown in Figure 2.2. Provided that a sample set has 
been already analyzed by random forests, the same sample set wi l l be analyzed again by 
an allelic chi-square test/Fisher's exact test as well. The criteria for using Fisher's exact 
test instead of allelic chi-square test are the same as discussed in Section 2.2.3. After this 
step, a list of candidate SNPs was generated for further analysis in the second stage of the 
association study, which was also examined by the allelic chi-square test/Fisher's exact 
test, as discussed in Section 2.2.3. This set of experiments using purely chi-square test 
serves as negative controls for the two-stage association study examined by the random 
forests and allelic chi-square test. Results generated by these two methods were 
compared as described in the following sections. Analysis by allelic chi-square 
test/Fisher's exact test mentioned within this section was implemented by PLINK 
(Version 1.04) (Purcell et al. 2007; Purcell 2008). 
2.2.5. Comparison of results: random forests plus chi-square test versus chi-square 
test 
We applied two methods, random forests plus allelic chi-square test and allelic 
chi-square test alone to 10 pairs of sample sets to generate a series of candidate SNP lists. 
Once a candidate significant SNP appears in one list, we add its count of hits by one and 
this is also checked in the other lists of candidate SNPs. Given 10 sets of paired samples, 
the range of hits count would be from one to ten. Thus, I finally generated a table 
indicating the number of hits for all candidate SNPs appearing in any of the SNP lists. 
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This allows us to compare the number of hits for candidate SNPs detected by the two 
different methods. Moreover, the number of hits for a candidate SNP was ranked by its 
level of significance using allelic chi-square test in the original sample set before 
application of clustering techniques. This allows me to compare the robustness between 
the clustering method (SOM plus K-means) plus two-stage method (random forests and 
chi-square test) and the used of chi-square test in the original sample set in terms of their 
ability to detect the same candidate SNPs and their significance levels. 
2.2.6. Validation of results on the whole sample set by allelic chi-square test 
We tested associations between SNPs and type 2 diabetes by allelic chi-square 
test on the whole sample set, which was refined by disposing of low-quality samples with 
call rate lower than 90%, as mentioned in Section 2.1.2. Analysis by allelic chi-square 
test/Fisher's exact test mentioned within this section was implemented by PLINK 
(Version 1.04) (Purcell et al. 2007; Purcell 2008). As a result, a list of significant SNPs 
was created and ranked based on their levels of significance. This list of significant SNPs 
was compared with the two lists of candidate SNPs with their hits count generated by 
random forests plus allelic chi-square test and solely by allelic chi-square test. 
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Figure 2.2: Flow chart of 2-stage genetic screening and analysis of cumulative risk-
conferring effects of discovered candidate SNPs. (a) Flow chart of 2-stage analysis using 
random forests plus chi-square test/2-stage analysis using chi-square test only/1-stage 
analysis using chi-square test only. *Note that 42 samples with a SNP call rate less than 
90% were removed from the sample sets created by SOM and K-means clustering. Thus, 
each pair of the sample sets contains 734 samples in total, (b) Flow chart of analysis of 
cumulative risk-conferring effects of six candidate SNPs. **Note that this analysis was 
implemented in the refined dataset consisting of 734 samples in total, as mentioned in (a). 
2.2.7. Extensions of the study: cumulative effects of candidate SNPs on disease risk 
of type-2 diabetes 
Cumulative risk-conferring effects of candidate genetic factors for type-2 diabetes 
were analyzed based on results generated by random forests and subsequently allelic chi-
square test. The candidate SNPs with more than a single hit among ten experiments were 
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retained in the whole sample set. Only samples with a SNP call rate above 90% were 
retained for study of their cumulative effects. I used Haploview (Version 4.1) (Barrett, 
Fry et al. 2005) for LD detection and SPSS 15 for odds ratio computation and logistic 
regression analysis as previously described (Lyssenko et al. 2008; Zheng et al. 2008). 
(1) LD detection: According to analysis of cumulative effects described by Zheng, 2008 
(Zheng et al. 2008), LD detection is required to select candidate SNPs with independent 
effects on phenotypes. Here, an LD detection was carried out by Haploview (Version 4.1) 
(Barrett et al. 2005) over the candidate SNPs with more than a single hit, as mentioned 
before. A single representative SNP among the candidate ones within any predicted LD 
block was carefully selected based on their hits count. In other words, the SNP with the 
largest number of hits was selected as the representative SNP for a particular LD block. 
(2) Selection of the best model for candidate SNPs: To address issue on selection of the 
best genetic model for a particular candidate SNP, I used logistic regression analysis for 
each candidate SNP based on three possible genetic models (i.e. dominant, recessive and 
multiplicative/additive) (Zheng et al. 2008). The criteria for goodness of fit of models are 
-2 log likelihood and pseudo r-square of models (Paultre and Mosca 2005). The fitting 
model with the least value of -2 log likelihood and the largest pseudo r-square was 
considered as the final model for a candidate SNP. The range of pseudo r-square is [0’ 1] 
and when this value is close to one, it indicates a good fitting model. 
(3) Encoding candidate SNPs based on their best genetic model: Odds ratio for a single 
SNP in a logistic regression model is equal to exp{|3i}. When the value of odds ratio is 
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below one, it indicates the minor allele a is protective against a disease. Based on analysis 
in step 2, I was able to encode a candidate SNP based on its best genetic model. The 
actual codebook for candidate SNPs is as follows, supposing a is the minor allele and A 
is the major allele of a gene. The code for a genotype indicates the number of risk factors 
that a carrier with a particular genotype may carry. For example, i f the minor allele a is a 
protective allele and the best model for the SNP is an additive model, then a person with 
a genotype A A at this SNP carries two risk factors. After the coding, all genotypes except 
the missing ones in the sample set were converted into a count of risk factors. The 
analysis of cumulative risk-conferring effects of discovered candidate SNPs was 
implemented in the refined dataset consisting of 734 samples without any missing 
genotypes (Figure 2.2). 
Best genetic model Genotypes Code 
Dominant AA/Aa/aa 1/1/0 
Recessive AA/Aa/aa 1/0/0 
Additive (multiplicative) AA/Aa/aa 2/1/0 
Table 2.3: Codebook for five possible genetic models of SNPs, assuming that the minor 
allele a is a protective allele against a disease. 
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Best genetic model Genotypes Code 
Dominant AA/Aa/aa 0/1/1 
Recessive AA/Aa/aa 0/0/1 
Additive (multiplicative) AA/Aa/aa 0/1/2 
Table 2.4: Codebook for five possible genetic models of SNPs, assuming that the minor 
allele a is a risk-conferring allele for a disease. 
(4) Analysis of cumulative effects of candidate SNPs: Firstly, the number of risk-
conferring genetic factors for each sample was counted based on tables 2.3 & 2.4. I then 
counted the number of samples that carried the same amount of risk factors respectively. 
Thus, a «x2 contingency table (the number of carried risk factors versus disease status) 
was created where n was the number of possible counts of risk factors (e.g., n = b - a + 1 
i f the number of risk factors for a sample has a range of [a, b]). This was followed by a 
logistic regression using n x2 contingency table to detect whether the number of carried 
risk factors was significantly correlated with disease risk. Note that there might be very 
few elements in the first few cells or the last few cells (i.e., the cells with a number of risk 
factors that is close to a or b). Thus, the first or the last few rows were merged together in 
order. Suppose that there are one or two cells with less than five elements in each of the 
first c rows, the first c+1 rows wi l l be merged into a single row containing two cells for 
cases and controls respectively. For example, i f this is the case in the first three rows for a 
9x2 contingency table and the range of the number of risk factors is [3, 11], then the first 
four rows wi l l be merged into a new row and the number of risk factors for samples in the 
two cells of the new row wi l l be set as "below 6". The same treatment was adopted for 
the last few rows i f there are one or two cells with fewer than five elements in each of 
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these rows. A Pearson's chi-square test was carried out for this modified contingency 
table to detect overall significance of possible correlation between the number of carried 
risk factors and disease status. Next, an ordinary chi-square test was followed up for each 
possible 2x2 contingency table to compare the proportion of cases in the baseline row 
and in any other row, thereby generating an odds ratio for it. For example, for a modified 
6x2 contingency table, the number of risk factors is possibly below 6, 6, 7，8, 9 and 
above 9. There wi l l be five possible 2x2 contingency tables (below 6 & 6, below 6 & 7, 
below 6 & 8，below 6 & 9 and below 6 & above 9). A chi-square test was simply 
completed over each of the five 2x2 contingency tables to compute their odds ratio. In 
summary, cumulative association between the number of carried risk factors and disease 
status was analyzed by logistic regression and chi-square test on different modified 
contingency tables, as discussed above. 
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CHAPTER 3. Results 
3.1. Effects of sample classification by SOM and K-means clustering 
In our experiment, U-matrix and corresponding component planes were applied to 
visualize classification result of cases or controls by SOM. Figure 3.1 displays the U-
matrix (Figure 3.1 (a)) and the component planes (Figure 3.1 (b)) for cases. Note that 
each of the sixteen component planes corresponds to a phenotype in this database, which 
is used for classification of cases. Moreover, SOM for controls only has fourteen 
component planes for AGE一ONSET and DURATION are not applicable to controls. 
Figure 3.2 shows the U-matrix (Figure 3.2 (a)) and the component planes (Figure 
3.2 (b)) for controls. Maps of SOM visualization, including both U-matrices and 
corresponding component planes for cases and controls, are called hot maps, where units 
with dark color on the SOM grid indicate relatively low value of a variable and others 
with light color indicate relatively high value of the variable. Particularly for U-matrices, 
as shown in Figure 1.7 (a), the distance units between a pair of neurons with dark color 
indicate a close distance between the two neurons. For example, in Figure 3.1 (a), 
neurons x & y are very close to each other because their distance unit 1 is darkly colored. 
Note that for component planes of discrete variables (e.g., SEX, D M & MES_NECPA), 
color of neurons indicates the probability of certain status. For example, for the 
component plane of DM, a neuron with light color showing a value close to 1 indicates 
that members within its Voronoi set are prone to suffer from type-2 diabetes. Besides, we 
did not manually detect any apparent clusters of neurons from Figure 3.1 (a) and Figure 
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3.2 (a). Instead, neurons on the SOM grid were further classified into different clusters 
through an automatic process by K-means clustering on neurons, as discussed below. 
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Figure 3.1 (a) U-matrix for SOM visualization based on classification result of cases. Hot 
map is used here to demonstrate degree of proximity between any two neurons involved 
in the SOM grid. Neurons x & y are separated from a distance unit 1. The dark color of 
this distance unit indicates a relatively short distance between the two neurons; in other 
words, members within their Voronoi sets have similar attributes with each other. 
51 
CHAPTER 3. Result 
AGE AGE-ONSET 
^^^^^^ P^y��_ P^YVTVtVYS _ 
d d 
BMI DBP 
28.1 ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ 
—�^ BxSS I 
d d 
Figure 3.1 (b) Component planes for SOM visualization based on classification result of 
cases. AGE: age of patients; AGE ONSET: the year when type-2 diabetes was diagnosed; 
BMI: body mass index; DBP: diastolic blood pressure. 
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Figure 3.1 (b) (Cont'd) Component planes for SOM visualization based on classification 
result of cases. DURATION: disease duration; FBS: fasting plasma glucose (FPG); HDL-
C: high-density lipoprotein cholesterol; HIP: hip circumference. 
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Figure 3.1 (b) (Cont'd) Component planes for SOM visualization based on classification 
result of cases. INSO: insulin level at OGTT at zero minute; LDL-C: low-density 
lipoprotein cholesterol; MES_NECPA: marker indicating whether a person suffers from 
metabolic syndrome (MES). Units with a value that is close to one indicate members 
within their Voronoi sets are more likely to suffer from MES and other units with a value 
that is close to zero indicate members within their Voronoi sets are less likely to suffer 
from MES; SBP: systolic blood pressure. 
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Figure 3.1 (b) (Cont'd) Component planes for SOM visualization based on classification 
result of cases. SEX: sex of patients. Units with a value that is close to two indicate there 
are more female members within their Voronoi sets and other units with a value that is 
close to one indicate there are more male members within their Voronoi sets; TC: level of 
total cholesterol; TG: level of triglyceride; WAIST: waist circumference. 
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Figure 3.2 (a) U-matrix for SOM visualization based on classification result of controls. 
Hot map is used here to demonstrate degree of proximity between any two neurons 
involved in the SOM grid. 
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Figure 3.2 (b) Component planes for SOM visualization based on classification result of 
controls. AGE: age of controls; BMI: body mass index; DBP: diastolic blood pressure; 
FBS: fasting plasma glucose (FPG). 
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Figure 3.2 (b) (Cont'd) Component planes for SOM visualization based on classification 
result of controls. HDL-C: high-density lipoprotein cholesterol; HIP: hip circumference; 
INSO: insulin level at OGTT at zero minute; LDL-C: low-density lipoprotein cholesterol. 
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Figure 3.2 (b) (Cont'd) Component planes for SOM visualization based on classification 
result of controls. MES NECPA: marker indicating whether a person suffers from 
metabolic syndrome (MES). Units with a value that is close to one indicate members 
within their Voronoi sets are more likely to suffer from MES; SBP: systolic blood 
pressure. SEX: sex of patients. Units with a value that is close to two indicate there are 
more female members within their Voronoi sets; TC: level of total cholesterol. 59 
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Figure 3.2 (b) (Cont'd) Component planes for SOM visualization based on classification 
result of controls. TG: level of triglyceride; WAIST: waist circumference. 
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After cases were handled with SOM, neurons on the SOM grid were further 
clustered by K-means clustering. Figure 3.3 & 3.4 show results by K-means clustering 
technique on the SOM map for cases and controls respectively. Clusters were colored 
differently on the original SOM grid. The best number of clusters is nine for both control 
and case subjects, which was determined automatically by the DB-indices of clustering 
results. The best clustering has the least value of DB-index. SSE (i.e., squared sum of 
errors) was used as reference rather than a criterion for selection of best clustering result. 
Compared with DB-index for both groups, SSE decreases and gradually converges as the 
number of clusters goes up. As discussed in Section 2.1.1, the class for a case or a control 
was considered the same as the class of its corresponding BMU on the SOM grid. After 
the class for each sample was settled, samples within the same cluster were equally 
separated into two independent sample sets. 
Note that samples with a call rate less than 90% were discarded from both sample 
sets, the adjusted sample sets for the first stage and the second stage of association study 
actually have slightly different number of samples (i.e., sample set for the first stage: 361 
samples; sample set for the second stage: 373 samples). However, the slight difference in 
the number of samples in each pair of sample sets did not generate any apparent bias on 
the result of association study in the subsequent stages. 
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Figure 3.3: Result of K-means clustering on SOM for cases, (a) (upper graph) Clusters of 
neurons on the SOM grid. The best number of clusters is nine, (b) (lower graph) Value of 
DB-index & SSE (squared sum of errors (Vesanto et al. 2000)). When the number of 
clusters is nine, the result has the least value of DB-index. 
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Figure 3.4: Result of K-means clustering on SOM for controls, (a) (upper graph) Clusters 
of neurons on the SOM grid. The best number of clusters is nine, (b) (lower graph) Value 
of DB-index & SSE (squared sum of errors (Vesanto et al. 2000)). When the number of 
clusters is nine, the result has the least value of DB-index. 
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3.2. Genetic associations in stage 1 
As mentioned in the previous section, samples of low quality (i.e., samples with a 
call rate less than 90%) were discarded from the original database containing 776 
samples in total. As a result, the sample set for the first stage of association study 
contains 361 samples (138 controls, 223 cases) and the sample set for the second stage 
has 373 samples (145 controls, 228 cases). Later, random forests (RF) were applied to 
select candidate SNPs in the first stage of association study. Training process of random 
forests was carried out iteratively for ten times. During each iteration, only SNPs with 
positive z-score were retained for the next iteration. Figure 3.5 shows the trend of average 
error rate for each of the ten training rounds. The average error rate, which is an average 
o f weighted classification errors for cases and controls, decreases and gradually 
converges within each training round. This finding was validated in Figure 3.6，where the 
mean value of average error rate gradually converges as the training process continues. 
Table 3.1 shows the overview of performance of random forests for each training round. 
On average, 93 SNPs were selected as candidate SNPs for further analysis in the 
secondary stage of association study with a selection ratio of approximately 4.9% (93 
candidate SNPs out of 1895 SNPs). Later, the selected candidate SNPs for each of the ten 
rounds were filtered using allelic chi-square test in an independent sample set, as 
discussed in the next section. Note that in parallel, another allelic chi-square test was 
carried out on the same sample set during each of the ten rounds. Similarly, a list of 
candidate SNPs with p-value below 0.05 was generated in each round. As discussed in 
Section 2.2.5, the 2-stage analysis using random forests plus chi-square test or solely chi-
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Figure 3.6: Mean value and error bar of average error rate for each iteration. The mea 
value and the confidence intervals were estimated on the ten average error rates amon 
different training rounds of random forests. 
Round B ^ I TP I TN I FP I FN I Sen Spec (%) PPV NPV (%) Ave acc 
iteration (%) 
1 10th 176 117 21 47 78.9 84.8 89.3 71.3 81.2 
2 8th 170 109 29 53 76.2 79 85.4 67.3 77.3 
3 7th 174 101 37 49 78 73.2 82.5 67.3 76.2 
4 9th 168 109 29 55 75.3 79 85.3 66.5 76.7 
5 6th 167 111 27 56 74.9 80.4 86.1 66.5 77 
6 9th 176 111 27 47 78.9 80.4 86.7 70.3 79.5 
7 6th 174 106 32 49 78 76.8 84.5 68.4 77.6 
8 8th 168 106 32 55 75.3 76.8 84 65.8 75.9 
9 10th 170 106 32 53 76.2 76.8 84.2 66.7 76.4 
10 6th 169 116 22 54 75.8 84.1 88.5 68.2 78.9 
Ave / 171 109 I 29 I 52 I 76.8 79.1 85.7 67.8 77.7 
Table 3.1: Overview of performance of random forests in classification of OOB sampk 
among the ten training rounds. Best iteration: the iteration that RF show the least averag 
error rate; TP: true positive; TN: true negative; FP: false positive; FN: false negative; Se 
sensitivity; Spec: specificity; PPV: positive predictive value; NPV: negative predicti\ 
value; Ave acc: average accuracy = 1 - average error rate; # candidate SNPs: the numb( 
of SNPs that were selected for the second stage of association study. The last row 
the average value of columns 3-12. 
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3.3. Genetic associations in stage 2 and validation of results 
Candidate SNPs generated in each round of the first stage were analyzed again 
through allelic chi-square test on the other independent sample set. As mentioned in 
Section 2.2.3-6，we counted the number of hits for candidate SNPs that appeared to be 
significant by allelic chi-square rest in the second stage and candidate SNPs were ranked 
according to their individual hits count. In parallel, the 2-stage analysis was also 
implemented using solely chi-square test as mentioned in Chapter 3.2. Similarly, I 
counted the number of hits for candidate SNPs that ever appeared in the result of 
association study using allelic chi-square test. Finally, we applied allelic chi-square test 
on the modified original sample set containing 734 samples as a validation of the results 
using random forests plus chi-square test and using chi-square test. 
Figure 3.2 shows the hits count for candidate SNPs generated by combined 
analysis using random forests and chi-square test. Figure 3.3 shows the hits count for 
candidate SNPs by chi-square test in both sample sets. Some of these candidate SNPs 
selected by either method were not significant using allelic chi-square test in the modified 
original sample set containing 734 samples. 
O f the 42 SNPs selected by the hybrid method of random forests and chi-square 
test, 12 SNPs showed more than one hit. Of the 29 SNPs selected by double chi-square 
tests, 15 SNPs had multiple hits. The maximal hits count of candidate SNPs selected by 
random forests plus chi-square test is 6 (rs7754840) and the corresponding SNP selected 
by double chi-square tests is 9 (rs 12437434). However, both methods did not detect some 
candidate SNPs that were significant by allelic chi-square test on the modified original 
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sample set containing 734 samples where 122 candidate SNPs were found to have 
nominal significant p-value. 
CHR SNP BP I A1 I A2 I # hits p - va luT 
6 rs775484Q 20769229 C G 6 0.000646 
6 rs1569699 20787289 A C 4 0.000228 
6 rs7752906 20774034 A G 4 8.65E-05 
14 rs 12437434 23948210 T C 4 8.12E-05 
1 rs13551 24053549 G A 2 0.000337 
I rs4240872 152702819 C T 2 ^0.05 
6 rs12523992 2624675 A G 2 >0.05 
I I rs2237892 2796327 T C 2 0.000338 
12 rs 1056007 21423405 T G 2 >0.05 
13 rs1408888 71326648 G T 2 0.000173 
19 rs3827011 17471857 G A 2 0.00338 
20 rs2236160 33565235 C T 2 >0.05 
1 rs12403023 166353623 G A 1 >0.05 
1 rs141Q244 165355097 G T 1 >0.05 
3 rs 1158265 24311166 C T 1 >0.05 
3 rs 1705738 24163710 T C 1 0.003783 
3 rs6762027 192436329 A G 1 0.01126 
3 rs844107 24138025 A G 1 0.009463 
4 rs5018647 6343700 T G 1 >0.05 
5 rs 155979 95795654 C G 1 >0.05 
6 rs1449675 156384314 C T 1 0.002543 
6 rs6931514 20811931 G A 1 0.000441 
6 rs7756992 20787688 A G 1 0.000609 
7 rs10755864 94301824 C T 1 >0.05 
7 rs963323 12376637 C T 1 >0.05 
8 rs4149244 27433079 T C 1 >0.05 
10 rs10794629 125440482 T A 1 >0.05 
10 rs2797491 5828614 G C 1 0.04703 
11 rs2282488 73665815 A G 1 >0.05 
11 rs319016 88820756 A G 1 >0.05 
11 rs319029 88816367 C G 1 >0.05 
11 rs4057749 123799446 G A 1 0.02697 
13 rs1413119 58237282 G A 1 0.001429 
13 rs17791181 71327504 C T 1 0.001145 
14 rs2401751 88016375 | T | C | 1 >0.05~ 
70 
CHAPTER 3. Result 
CHR SNP BP I A1 I A2 I # hits p-value 
15 rs 11852861 56623600 T C 1 >0.05 
15 rs743582 72115259 C G 1 >0.05 
18 rs9958734 45372396 C T 1 >0.05 
19 rs2270937 54177570 A G 1 >0.05 
19 rs8104812 57579249 C A 1 >0.05 
22 rs2269380 49395266 C T 1 0.02127 
22 rs738935 45690068 | A | T | 1 >0.05~ 
Table 3.2: Hits count of candidate SNPs generated in the second stage using the testing 
set (RF). This table shows the result of association analysis carried by random forests in 
the first stage and chi-square test in the second stage. CHR: chromosome number; BP: 
base pair; A l : minor allele; A2: major allele; # hits: hits count of candidate SNPs; p-
value: the significance level of allelic chi-square test on the whole sample set. In 
significant SNPs were marked as ">0.05". 
CHR SNP BP I A1 I A2 I # hits p-value 
14 rs12437434 23948210 T C 9 8.12E-05 
11 rs2237892 2796327 T C 8 0.000338 
6 rs7752906 20774034 A G 8 8.65E-05 
6 rs7754840 20769229 C G 8 0.000646 
6 rs1569699 20787289 A C 7 0.000228 
6 rs7756992 20787688 A G 7 0.000609 
1 rs 13551 24053549 G A 6 0.000337 
6 rs6931514 20811931 A G 6 0.000441 
13 rs1408888 71326648 G T 5 0.000173 
13 rs1413119 58237282 G A 4 0.00142^ 
6 rs 1449675 156384314 C T 3 0.002543 
19 rs3827Q11 17471857 G A 2 0.00338 
13 rs17791181 71327504 C T 2 0.001145 
3 rs 1449874 24246832 A G 2 >0.05 
3 rs17629834 159803397 C A 2 >0.05 
2 rs715326 27579265 A G 1 0.004027 
9 rs10811661 22124094 C T 1 0.001547 
4 rs 13846 110825193 T A 1 0.002116 
3 rs1705738 24163710 T C 1 0.003783 
5 rs155979 95795654 C G 1 >0.05 
5 rs174006 128359355 G A 1 >0.05 
7 rs10755864 94301824 C T 1 ^0.05 
7 rs963323 12376637 | C | T | 1 >Q.05~ 
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CHR SNP BP I A1 I A2 I # hits p-value 
8 rs281 19859303 T A 1 >0.05 
9 rs10761084 106570973 C G 1 >0.05 
11 rs319030 88815035 C T 1 >0.05 
15 rs4594196 58614722 C T 1 >0.05 
15 rs7165654 56627331 G A 1 >0.05 
19 rs227Q937 54177570 | A | G | 1 >0.05 
Table 3.3: Hits count of candidate SNPs generated in the second stage (chisq). This table 
shows the result of association analysis carried by purely chi-square test in the first stage 
and the second stage. CHR: chromosome number; BP: base pair; A l : minor allele; A2: 
major allele; # hits: hits count of candidate SNPs; p-value: the significance level of allelic 
chi-square test on the whole sample set. In significant SNPs were marked as ">0.05". 
“ C H R SNP BP p-value # hits (chisq) # hits (RF) 
6 rs7754840 —20769229 0.000646 8 6 
“ 1 4 rs 12437434 "^3948210 8.12E-05 9 4 
— 6 rs7752906 20774034 8.65E-05 8 ~ 4 
6 rs1569699 20787289 0.0002279 7 ~ 4 
13 rs 1408888 71326648 ~0.0001726 5 2 — 
一 1 rs13551 24053549 0.0003368 6 2 
一 11 「S2237892 2796327 0.000338 8 2 一 
一 19 rs3827011 17471857 0.00338 2 ~ 2 
“ 6 rs6931514 "^0811931 0.0004408 6 1 
6 「S7756992 20787688 0.0006092 7 1 一 
~ 13 rs17791181 71327504 0.001145 2 1 — 
13 rs1413119 58237282 ~0 .001429 4 1 — 
一 6 rs 1449675 ~56384314 0.002543 3 1 
~ 3 rs1705738 ~24163710 0.003783 — 1 1 
“ 3 rs844107 24138025 ~ 0.009463 — 0 1 
3 rs6762027 "T92436329 0.01126 0 1 
一 22 rs2269380 49395266 —0.02127 0 1 
一 11 rs4057749 123799446 ~~0.02697 0 1 
“ 2 2 rs738935 45690068 — 0.02861 ~ 0 1 
一 10 rs2797491 5828614 ~~~0.04703 0 1 
9 rs10811661 22124094 ~~0.001547 1 0 — 
4 rs13846 110825193 0.002116 1 0 
4 rs10021007 166590962 0.003405 0 0 — 
2 rs715326 "^7579265 — 0.004027 1 0 
11 "7^074196 2781376 0.004074 0 0 
3 "~rs826386 24162504 0.004648 0 0 
一 3 rs826381 24149490 0.005762 0 0 — 
“ C H R SNP BP p-value # hits (chisq) # hits (RF) 
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18 rs1791351 55597063 0.005769 0 | 0 一 
3 rs1126478 46476217 0.00617 0 0 
2 rs813592 —27575475 0.006363 — 0 0 
2 rs8179252 27600336 0.007089 0 0 
2 rs2293571 27582984 ~~0.007441 0 0 ~ 
3 rs1063539 188058086 ~~0.007465 0 0 
10 rs227506Q 71959784 0.007812 0 0 
7 rs2572023 ""^312363 0.009795 0 0 
3 "7^241766 188053586 0.0103 0 0 
3 rs2363980 192433889 0.0103 0 0 
4 rs4862653 187314200 0.01046 — 0 0 
~ 1 4 rs7157977 30927960 0.01052 0 0 
15 ~~r^311892 67113785 "“ 0.01155 0 0 
一 16 rs904763 70330691 0.01179 0 0 
—1 3 rs9572813 71324431 0.01211 0 0 — 
6 rs2268657 39128520 0.01306 0 0 
20 rs4812828 42413734 0.01347 0 0 
2 rs17189743 ~M336057 — 0.01357 0 0 
— 3 rs2340917 14150263 0.01462 0 0 
— 3 rs826378 24144730 0.01505 0 0 
18 rs4941050 ""^555166 0.0154 “ 0 0 
~ 1 rs10918682 ~165548618 0.01551 0 0 
— 6 rs987105 ~ ^ 2 7 4 7 3 7 0.01629 0 0 
~ 19 rs3764618 88967 0.01664 0 0 
2 rs780094 ~ ^ 5 9 4 7 4 1 0.01699 0 0 
11 rs2510152 118653783 — 0.01718 0 0 
3 rs3752874 59999 ~ 0.01963 0 0 
3 rs2034771 192450473 0.02078 0 0 
17 rs1076423 15813875 0.02186 0 0 — 
15 rs2242062 56621683 ~ 0 . 0 2 2 2 7 ~ 0 " 0 — 
1 rs1347251 151535808 0.02286 0 0 
—11 rs10897430 63032139 0.0229 ~ 0 " 0 — 
3 rs12494322 192441063 0.02343 0 0 
2 rs 1500480 234392817 0.0236 0 0 
3 rs1667738 24165350 0.02361 0 0 ~ ~ 
5 rs11135457 95758524 0.02409 0 0 
—1 0 rs17130188 114858152 0.0241 0 0 
18 rs7241506 57550889 — 0.02507 0 0 
I rs 12405278 1 5 0 5 4 8 8 9 1 0.02573 0 0 
—11 rs4148646 17371766 0.02626 0 0 — 
I I �S6589722 118590993 0.02796 0 0 
—22 rs401416 16642946 0.02801 ~ 0 ~ 0 
—CHR SNP BP p-value # hits (chisq) # hits (RF)~ 
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一 20 rs1884614 42413933 0.02813 | 0 | 0 
- 4 rs13126038 "166553239 0.02826 0 0 
_ 3 rs826373 "^4138777 — 0.0286 0 0 
11 rs4936467 ~Tl 8591839 — 0.02862 0 0 
“ 8 rs6980476 ~~87588431 — 0.02881 0 0 
4 rs6841638 "166589111 0.02934 0 0 
- 1 8 rs7229901 72267935 0.02968 0 0 
10 rs7923837 ~94471897 0.03015 0 0 
10 rs1219819 125434649 ~~0 .0309 0 0 — 
1 �S2987763 151552658 0.03097 0 0 
10 rs11196229 114856162 0.03145 0 0 — 
1 rs689466 184917374 0.03235 0 0 — 
2 rs1260326 ~27584444 0.03293 0 0 
" “ 1 0 rs4918789 "Tl4811797 — 0.03321 0 0 
- 3 rs 17014487 "^4319631 0.03334 0 0 
- 1 1 rs6589729 " T l 8671861 0.0335 0 0 
" “ 1 5 rs868115 ~67062865 0.03368 0 0 
一 20 rs2144908 ~42419131 0.03371 0 0 
一 12 rs17836273 3659713 —0.03435 0 ~ 0 
一 8 rs3736281 24405307 0.03488 ~ 0 0 
— 1 rs6698181 88915893 0.03561 0 — 0 — 
~ 3 rs696217 10306457 —0.03567 0 0 — 
“ 2 0 rs17755638 ~42421255 0.03683 — 0 0 
22 rs881740 44946052 0.03721 0 0 — 
10 rs3814570 114698500 0.03861 0 ~ 0 
13 rs7326603 ~21156775 0.03906 0 0 
- 1 0 rs65852Q5 ~Tl4849154 0.03941 0 0 
“ 1 0 rs290489 114897045 0.04016 — 0 0 
“ 1 1 rs2510139 118669887 — 0.04025 ~ 0 0 
" “ 6 rs12210441 138358696 0.04041 0 0 
— 1 6 rs8Q59048 87308541 ~~0.04047 0 0 — 
— 7 rs6947766 105697902 0.04081 0 0 — 
一 1 rs10737346 178818883 —0.04093 0 — 0 — 
一 10 rs4304670 94321119 ~~0.04105 0 一 0 — 
19 rs279205 11875274 0.04108 0 一 0 
“ 1 4 rs11621754 20171297 — 0.04133 0 0 
“ 1 1 rs11217188 118593386 — 0.04325 — 0 0 
一 5 rs3849746 1 ^ 9 9 1 5 1 0 —0.04334 0 0 — 
~ 3 rs826374 24138925 0.04368 0 0 — 
~ 12 rs2307027 " ^ 4 9 0 8 8 1 0.04398 0 0 — 
13 rs11069344 —98512511 0.0447 0 0 
12 ~rs1871139 21604197 0.04473 0 0 
一 CHR SNP BP p-value | # hits (chisq) | # hits ( R 『 
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10 rs2254067 5821634 0.04486 I 0 I 0 
- 1 6 rs4036 2761526 —0.04562 0 0 ~ ~ 
“ 2 1 rs2183573 39496175 0.04622 0 0 
3 rs2972164 ~~12309416 0.04699 0 0 
17 rs2269769 ~45528164 0.04723 0 0 
17 rs2526354 ~~55331440 0.04754 ~ 0 0 
- 2 0 rs8117664 17200516 0.04816 — 0 0 
- 1 3 rs4883918 72248080 — 0.04846 0 0 
- 1 rs6681720 171651045 0.04885 0 0 
3 rs4858604 ~^4324919 0.04917 0 0 
19 rs812936 5795649 0 04979 | 0 | 0 
Table 3.4: Result of allelic chi-square test in the modified original sample set containing 
734 samples. CHR: chromosome number; BP: base pair; p-value: significant level of chi-
square test; # hits (chisq): hits count for candidate SNPs through analysis by purely chi-
square test in the first stage and the second stage; # hits (RF): hits count for candidate 
SNPs through analysis by random forests in the first stage and chi-square test in the 
second stage. 
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3.4. Cumulative effects of candidate SNPs on risk of developing type 2 diabetes 
As discussed in Section 2.2.7, cumulative effects of candidate SNPs were 
analyzed to ascertain possible gene-gene interactions on risk of type 2 diabetes. For this 
part of the analysis, I only included candidate SNPs that were selected by random forests 
and chi-square test with multiple hits which were also significant by chi-square test in the 
modified original sample set with 734 samples. A l l these candidate SNPs do not share 
common LD blocks. 
Before I examined the joint effects of these candidate SNPs, I used "Solid spine 
of LD" algorithm in Haploview to detect LD where the threshold for D' is 0.8. This 
algorithm is considered as the best method for LD detection which defines a block where 
the first and the last markers are in strong LD with all the other intermediate markers 
(Duggal et al. 2008). Figure 3.7 shows the result of LD detection, where three SNPs 
rs7754840, rs7752906 and rs 1569699 in the same gene CDKAL l share a common LD 
block. Hence, only rs7754840 with higher hits count than the other two SNPs within the 
same gene was selected together with the other five SNPs for analysis of cumulative 
effects of genetic factors. Table 3.5 shows the pairwise D' and r-square of LD between 
pairs of candidate SNPs. 
L1 I L2 I D， I r" 
rs7754840 rs775290^ 1 “ 0.991 
rs7754840 rs 1569699 0.844 0.477 
rs7752906 rs 1569699 0.854 “ 0.485 
rs 124374341 rs 13551 0.015 0 
Table 3.5: LD detection for candidate SNPs found by RF and chi-square test. L I : SNP 1; 
L2: SNP 2. The threshold for significant D' is 0.8. 
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Figure 3.7: LD detection for candidate SNPs found by RF and chi-square test. 
In order to determine the exact number of risk factors carried by each sample, we 
applied logistic regression on three possible models for each SNP (i.e., dominant, 
recessive and multiplicative/additive). The fitting model with the least value of -2 log 
likelihood and the largest pseudo r-square was selected as the final model for the SNP. 
Later, candidate SNPs were encoded based on their individual best genetic model as 
discussed in Section 2.2.7. Table 3.6 shows the result of logistic regression on three 
possible models for the six candidate SNPs. The actual type of minor allele (i.e., 
protective allele or risk-conferring allele) was determined by odds ratio. When odds ratio 
in the best model is below one, minor allele of the candidate SNP is protective; otherwise 
it is a risk-conferring allele. 
The model of logistic regression is logzY(;；) = /?(,+/?,* genotype , where y 
indicates risk of type-2 diabetes and genotype follows either of the three possible models. 
77 
CHAPTER 3. Result 
SNP MODEL p-value odds ratio -2 Log likelihood Cox & Snell r^  Nagelkerke r^  
rs 13551 ADD 0.00038 0.6560668" 964.058 0.017247479 0.023412178 
rs 13551 *DOM 0.00031 0.5755186 963.677 0.01775894 0.02410644^ 
rs13551 REC 0.08016 0.6254386 973.758 0.004137578 0.005616457 
rs7754840 ADD 0.0012 1.4281203 一 911.875 0.015544982 0.020993882 
rs7754840 *DOM~ 0.00014 1.8410753 _ 908.021 0.021076381 "~0028464172 
rs7754840 REC 0.1949 —1.3060884 920.884 0.002492702 " ^ 0 3 3 6 6 4 5 6 
rs2237892 *ADD 0.00023 0.6243475 901.49 0.019708954 “ 0.02683051^ 
rs2237892 DOM— 0.00176 —0.6089213 905.342 0.014220515 ~0019358905 
rs2237892 REC 0.00505 ~0.4237979 “ 907.262 0.011473508 "5^15619304 
rs1408888 ADD 0.00021 0.6414913 957.156 ~ a 01888483 0.02564004^ 
rs 1408888 DOM 0.00718 0.6627176" 963.773 0.009925878 0.013476426 
rs 1408888 *REC 0.00022 ~Q.3522876 956.852 0.019294458 0.026196204 
rs12437434 *ADD 0.00011 0.6292597 963.545 0.020495234 0.027830491 
rs12437434 DOM— 0.00132 —0.6121808 968.355 0.014054728 0.019084925 
rs12437434 REC — 0.00142 —0.4116269 968.38 0.014021386 0.019039649 
rs3827011 ADD 0.00386 ~1.3797426 970.24 0.011520525 0.015643728 
rs3827011 *DOM~ 0.00181 ~1.6244482 969.008 0.013177804 0.017894149 
rs3827011 REC 10.168571 1.3474595 | 976.806 0.002638132 0.00358232?^ 
Table 3.6: The best genetic model for candidate SNPs. ADD: additive/multiplicative 
model; DOM: dominant model; REC: recessive model, p-value and odds ratio were 
calculated in logistic regression (SNP vs. DM, without adjustment by age or sex). The 
best genetic model for candidate SNPs are marked by asterisks and highlighted in red. 
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Cumulative effects of candidate SNPs were firstly analyzed by logistic regression 
on the number of risk factors to predict type 2 diabetes. To avoid the need of using 
computation by Fisher's exact test, we modified the original contingency table as 
mentioned in Section 2.2.7 in which all cells have more than five elements. Pearson's 
chi-square test was carried out on this modified contingency table as well as on several 
2x2 contingency tables as follows. Note that the referent group carried ‘4 or fewer' (or 
fewer than 4, i.e. 3 or fewer) risk-conferring risk factors. Table 3.7 shows the result of 
analysis of cumulative effects of candidate SNPs on the risk of type-2 diabetes, which 
was carried out in the modified original sample set with 734 samples. In this logistic 
regression model, we found that the number of risk factors independently increased risk 
o f type 2 diabetes. Age and sex did not show any association. The presence of 1 risk 
factor increased risk by 60%. Chi-square test on the 6x2 contingency table (i.e., Table 3.7 
(c)) showed an overall significant p-value. Moreover, the odds ratio increases as the 
number o f risk factors increases, as shown in Table 3.7 (c), although the odds ratio (<4 vs. 
8) decreases again, which might be due to insufficient number of controls and cases 
carrying 8 risk factors. In Table 3.7(b), the logistic model is: 
咨 i t i y ) = Pq + sex + Pi* age ^^ p广 N risk factors , where y indicates risk of type-2 
diabetes and Nrisk factors indicates the number of risk factors for every sample. 
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Diyi 
control case Total 
# risk factors 1 3 0 3 
2 一 6 2 8 
3 27 一 7 34 
4 — 56 - 44 100 
5 一 67 89 156 
6 57 124 
7 一 31 96 127 
8 9 23 32 
Total 256 385 641 
Table 3.7 Cumulative effects of candidate SNPs on the risk of type-2 diabetes, (a) 
Distribution of number of risk factors in the sample set. Note that samples with missing 
genotypes were excluded from this analysis. 
Q C O / Q I 
variable p-value odds ratio A 
lower upper 
sex 0.903 — 1.022 ~0.722272 1.44566 
age 0.826 1.002 0.984979 1.01915 
-#r iskhctors 9.663E-13 1.611 1.41348 1.83706 
Table 3.7 Cumulative effects of candidate SNPs on the risk of type-2 diabetes, (b) Result 
of logistic regression on the number of risk factors to predict risk of diabetes with 
adjustment for sex and age. 95% CI: 95% confidence interval. 
/ r i s k c o n t r o l case chi-s，uare ^f approx. exact odds 95% CI 
factors value p-value p-value ratio lower upp< 
<4 — 36 9 ！ ^ NA NA M 1 NA NA 
4 56 44 7.708 1 0.0055 0.00859 14286 1.37~ 7.20S 
5 67 89 19.19 1 1.2E-05 1.5E-05 5.31343 "Z39642 11.75 
6 57 124 35.018 1 _ 3.3E-09 3.6E-09 ~8.70175 " ^ 9 8 3 19.26 
7 — 31 96 43.18 1 5E-11 6.6E-11 12.3871 5.37366 ^ ^ 
8 — 9 23 20.721 1 5.3E-06 6.6E-Q6 10.2222 3.53524 ^ ^ 
total 256 385 61.465 5 6.1E-12 NA NA | NA | N； 
Table 3.7 Cumulative effects of candidate SNPs on risk of type-2 diabetes, (c) Result of 
chi-square test. Note that the baseline of the number of risk factors is "below 4". 
control/case: the number of controls/cases; df: degree of freedom; 95% CI: 95% 
confidence interval. 
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CHAPTER 4. Discussion 
4.1. Overall strategy 
In this experiment, I implemented a 2-stage analysis by random forests and chi-
square test and compared the results in another 2-stage analysis using chi-square test in 2 
subsets of samples, followed by an additional chi-square test in the modified original 
dataset with 734 samples (Figure 2.1 & 2.2). I first improved the classification of the 
original sample set with 776 samples using SOM and the K-means clustering. The sample 
set was split into 2 subsets with similar number of samples (training set for selection and 
testing set for validation). This partitioning process was repeated for ten times, finally 
giving rise to ten pairs of sample sets for each of the two stages of the analysis. 46 
samples with a SNP call rate lower than 90% were removed from the original dataset and 
the ten pairs of sample sets generated by SOM and the K-means clustering. Then, I used 
random forests to select candidate SNPs which were validated by allelic chi-square test in 
the testing set to generate 10 lists of candidate SNPs using p-value less than 0.05 as level 
of significance. To assess the performance of this method, for the same subsets of 
samples, I used chi-square test to select candidate SNPs in the training set and validated 
them using chi-square test again in the testing set to give another list of candidate SNPs. 
In addition, I applied chi-square test to select candidate SNPs in the modified original 
dataset with 734 samples. I also counted the number of hits for each SNP during 
validation and ranked them by their p-values using chi-square test in the dataset with 734 
samples. Finally, I chose six tag SNPs among the discovered ones with multiple hits 
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generated by random forests and chi-square test and analyzed their cumulative risk-
conferring effects in risk of type 2 diabetes. 
4.1.1. Effects of SOM and K-means clustering 
The use of SOM and K-means clustering technique to improve classification of 
the sample set proves to be essential in our validation of candidate SNPs selected either 
by random forests or chi-square test in the second stage using chi-square test. There are 
now a large number of GWAS but most studies were only able to replicate a few 
candidate SNPs using large sample size. This discrepancy may be due to heterogeneity of 
the sample despite being labeled as cases or control which is a characteristic of many 
complex diseases with multiple phenotypic traits. Since population stratification within a 
sample set can attenuate the power to detect disease-associated SNPs or even generate 
biased results, it is not unexpected that unbalanced sample sets used in many of these 
two-stage experiments fail to replicate the candidate SNPs. 
In our experiment, we applied SOM plus K-means clustering on neurons of the 
SOM in a phenotype database to create pairs of balanced sample sets. This hybrid method 
has improved classification of the sample with similar distributions for many of the 
phenotypes available in the dataset. At the initial stage of the clustering process, it was 
not easy to detect any apparent clusters of neurons directly from the U-matrices for cases 
and controls (Figure 3.1(a) & Figure 3.2 (a)). However, it is possible to detect certain 
differences in the patterns of individual phenotype as indicated by neurons in a 
component plane (Figure 3.1(b) and Figure 3.2(b)). In the SOM grid, there were several 
regions formed by neurons as indicated by their color, suggesting that these neurons can 
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be classified into different clusters. Thus, samples within the same cluster may show 
similar levels of the shared phenotype. Nevertheless, it is too imprecise to manually 
detect possible clusters of neurons since component planes do not display consistent color 
distribution. Moreover, it is not possible to manually determine the major phenotype 
components or rank these phenotypes in order of importance during this preprocessing 
stage by SOM and K-means clustering. Thus, I improved the output of SOM using 
automatic K-means clustering. 
Figure 3.3 and Figure 3.4 show the trend of DB-index and SSE for K-means 
clustering when different numbers of clusters are adopted (i.e., the value of K). SSE 
shows a continuous decrease when the number of clusters increases so that K-means 
clustering with a larger K would probably have a lower SSE. As a result, SSE is not a 
proper criterion for determining the best number of clusters. To the contrary, DB-index 
did not show the same trend as SSE for both SOM on cases and controls. Since DB-index 
is used to measure the difference of performance of K-means clustering in the adjacent 
two training processes, it is more reliable in measuring the improvement of performance 
of the current K-means clustering process and helps determine the best number of 
clusters for classification of neurons. 
4.1.2. Effects of random forests in the first stage of association study 
As shown in Figure 3.5, there is an apparent convergence of average error of 
classification and the overall error decreases rapidly and becomes flattened out in late 
iterations with each training round. Figure 3.6 shows a similar decrease of average error 
rate during the training process of random forests. Indeed, the mean value of average 
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error rate remains stable and almost converges after the sixth iteration. Of note, candidate 
SNPs were not always generated from the last iteration. To the contrary, candidate SNPs 
were generated twice from the sixth iteration, just after average classification error 
converges. Although other types of measurements including sensitivity, specificity, PPV, 
NPV and the number of selected candidate SNPs are not always consistent among the ten 
training rounds (Table 3.1)，parameters of the ten rounds appear to be close to each other. 
Provided that more training rounds o f random forests are adopted in future association 
studies, it is likely to generate more consistent parameters during different training 
rounds. 
4.1.3. Comparison of our method with traditional chi-square test 
Table 3.2，3,3 & 3.4 show the overall results of this candidate SNP selection by 
the 1 -stage and the two types o f 2-stage analyses. We used the result of allelic chi-square 
test executed on the modified original sample set with 734 samples, which is shown in 
the column "p-value" of table 3.2/3.3/3.4 as the reference for comparing the performance 
o f the 2-stage analysis using random forests and chi-square test and the other 2-stage 
analysis using chi-square test in the modified original sample set with 734 samples. 
Firstly, neither of the two 2-stage analyses detected all the significant SNPs 
selected by the 1 -stage analysis, although there were overlaps amongst these 3 lists of 
candidate SNPs. Of the 49 candidate SNPs detected by random forests and chi-square test, 
26 SNPs were validated by allelic chi-square test in the modified original dataset. Of the 
29 candidate SNPs detected by 2-stage chi-square test, 17 SNPs were validated by chi-
square test in the modified original dataset. In other words, despite validation in the 
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testing set, some of these candidate SNPs selected in the training set cannot be replicated 
by chi-square test in the modified original sample set. Moreover, among the candidate 
SNPs found significant by chi-square test in the modified original and expanded sample 
set, merely 8 (by random forests plus chi-square test) and 13 SNPs (by purely chi-square 
test) show multiple hits in the ten rounds. This result suggests insufficient power for 
detection of candidate SNPs in our association study. To overcome this, it may be 
necessary to increase the number of rounds of the study. Thus, hundreds or even 
thousands of training rounds are required for this two-stage association study to identify 
candidate SNPs with multiple hits. While it is difficult to define the threshold for number 
of hits which may point to the trueness of the finding, a simulation study in another 
independent sample set is an alternative to determine the trueness of these findings. 
Comparing the two methods applied to the 2-stage analyses, Table 3.4 suggests 
that the traditional chi-square test used in both stages has stronger detection power than 
the hybrid method (i.e. random forests plus chi-square test). The highest hits count is 9 
for chi-square test only and 6 for random forests plus chi-square test. Same candidate 
SNPs found by both methods appear to have more hits count when purely chi-square test 
was applied. However, i f we adjust the p-value for chi-square test due to multiple 
comparisons using Bonferroni correction, the two methods actually generate the same list 
of candidate SNPs with multiple hits count. The adjusted p-value by Bonferroni 
correction should be 0.05/122 = 0.00041. Using this threshold of p-value, both methods 
detected the same list of candidate SNPs that were replicable by allelic chi-square test in 
the modified original sample set with 734 samples, including rs 12437434, rs7752906, 
rs 1569699, rsl408888, rsl3551 and rs2237892. From Table 3.4, we can also find that the 
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most nominally significant candidate SNPs (i.e. p < 0.05) were excluded from both 
methods once Bonferroni correction was adopted. Thus, the apparent robustness of thee 
chi-square test to detect significant SNPs was not upheld and our novel method of 
random forests plus chi-square test is in fact more conservative and generates less false 
positive candidate SNPs. 
Taken together, our method suggests that the use of different methods to select 
SNPs may reduce false positive finding and that the combined use of classification and 
decision algorithm such as random forests can discover novel SNPs which cannot be 
detected by conventional statistical test. Clearly, the validity of this hybrid method wi l l 
need to be confirmed in different studies with an increased number of training rounds. 
4.1.4. Joint effects of candidate SNPs selected by the hybrid method 
We have used logistic regression on the candidate SNPs found by random forests 
and chi-square test to detect their cumulative effects on the risk of type-2 diabetes to 
further verify their associations with disease. To ensure that the candidate SNPs have 
independent effects on the risk of type-2 diabetes, we calculated pairwise LD value 
between SNPs, as shown in Figure 3.7. Since rs7754840, rs7752906 and rs 1569699 come 
from the same gene CDKAL l and showed strong pairwise LD, only rs7754840 was 
selected for this study since it had the higher number of hits count amongst the 3 SNPs. 
The six candidate SNPs for analysis of their joint effects on type-2 diabetes were 
encoded based on results of their individual logistic regression against risk of diabetes 
with adjustment for sex and age. Table 3.6 shows the result of individual regression 
analysis, indicating that the level of significance shown by p-value is consistent with -2 
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log likelihood and inversely related to the two types of pseudo r-square. For example, the 
dominant model of rs 13551 has lower p-value and -2 log likelihood (0.0003; 963.7) than 
its recessive model (0.08; 973.8) which has a non-significant p-value of 0.08. These 
results indicate that recessive model is obviously not appropriate for rs 13551. Similar 
results were also found for other SNPs. However, for certain models for a candidate SNP, 
the significance of the models might be very similar. For example, the additive model and 
recessive model of rs 1408888 have very similar significant levels and -2 log likelihood 
and pseudo r-square. In this case, it is difficult to determine which model to adopt and I 
have chosen the model with the lowest value of -2 log likelihood and the highest value of 
pseudo r-square. The final result of the analysis of joint effects suggests that our selection 
approach was correct. Of note, the minor allele is not always "the risk-conferring allele" 
and may indeed be protective, as indicated by an odds ratio less than one. In our analysis, 
the minor allele of rsl3551, rs2237892, rsl408888 and rsl2437434 were all protective 
(Table 3.6). 
After we encoded genotypes of candidate SNPs by number of risk factors carried 
by cases and controls, we analyzed the joint effects of these candidate SNPs by logistic 
regression (Table 3.7). Firstly, whereas sex and age did not show significant p-value, the 
number of risk factors was strongly associated with risk of type-2 diabetes with a p-value 
of 9.663x10-13 with each risk factor conferring an odds ratio of 1.6 (Table 3.7(b)). These 
risk associations were further confirmed using individual chi-square test on successive 
2x2 contingency tables comparing between each possible n where n is the number of risk 
factors using "fewer than four" risk factors as referent group (Table 3.7(c)). 
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Since there were only very few samples with 1/2/3 risk factors, I grouped 
cases/controls with 3 or fewer risk factors into a single row. After this adjustment, the 
final result of the chi-square test on these contingency tables remains highly significant. 
Furthermore, the graded increase in odds ratio with increasing number of risk factors 
strongly suggests a gene-dose effect on disease risk. Compared to subjects with 3 or 
fewer risk factors, the odds ratio increased by 3, 5 and 8-folds respectively in subjects 
with 4, 5 and 6 risk factors. In subjects with 7 risk factors, the odds ratio increased to 12. 
The paradoxical fall of odds ratio to 10.2 in subjects with 8 risk factors were probably 
due to the small number of subjects in this category. Besides, the overall trend of the 
number of risk factors versus disease risk can be validated by chi-square test on the 6x2 
contingency table with a highly significant p-value of 6.1x10"^^ (Table 3.7(c)). 
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4.2. Biological significance of candidate SNPs 
Table 4.1 shows the genes and their locations where candidate SNPs selected by 
random forests and chi-square test with multiple hits are located. A l l these candidate 
SNPs are located within gene regions, which allows functional studies to be conducted to 
examine their effects on cellular function and structure. 
CHR SNP GENE LOCAlfoN BP p-value # Wts (RF) 
6 ~~ rs7754840 CDKAL1 6p22.3 20769229 0.000646 6 
14 rs 1243743^ KIAA1305 1 4 q 1 2 ~ 23948210 8.12E-05 4 
6 — rs7752906 CDKAL1 6 p 2 2 . 3 2 0 7 7 4 0 3 4 8.65E-05 4 
6 rs156969y C D K A L I 6 p 2 2 . 3 20787289 0.0002279 4 
13— rs1408888 DACH1 1 3 q 2 2 ~ 71326648 0.0001726 2 
I — rs 13551 FUCA1 1p34 24053549 0.0003368 2 
I I rs223789^ KCNQ1 11p15.y~ 2796327 0.000338 2 
19 rs3827011 SLC27A1 19p13.11 17471857 0.00338 2 — 
Table 4.1: Overview of genes where candidate SNPs are located. CHR: chromosome 
number; GENE: the gene where candidate SNP are located; p-value: significant level of 
chi-square test; # hits (RF): hits count for candidate SNPs through analysis by random 
forests in the first stage and chi-square test in the second stage. 
4.2.1. Gene CDKALI 
In this association study, three candidate SNPs rs7754840, rs7752906 & 
rsl569699 come from the same gene CDKALI (CDK5 regulatory subunit-associated 
protein 1-like 1) located in 6p22.3. This gene is expressed in human pancreatic islet and 
skeletal muscle and encodes a 579-residue, 65-kD protein with unknown function 
(Zeggin et al. 2007). However, this protein shares considerable domain with the CDK5 
regulatory subunit-associated protein 1 encoded by CDK5RAP1. The latter serves as an 
inhibitor of cyclin-dependent kinase 5 (CDK5) in neuronal tissues (Steinthorsdottir et al. 
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2007; Zeggini et al. 2007). Since CDK5 has been shown to be associated with loss of 
beta-cell function and decreased insulin gene expression, it is expected that CDKAL l 
may have similar intracellular functions in pancreatic islet as CDK5RAP1 in neuronal 
tissue (Steinthorsdottir et al. 2007; Zeggini et al. 2007). Moreover, carriers of risk alleles 
at C D K A L l gene locus, especially fetus, may display a lower birth weight, which is 
known to be associated with increased risk of type-2 diabetes (Freathy et al. 2009). 
Among the three candidate SNPs, rs7754840 has proven to be associated with type-2 
diabetes in multiple populations (Saxena et al. 2007; Palmer et al. 2008; van Hoek et al. 
2008). This candidate SNP is located in a 90-kb introns within CDKAL l (Saxena et al. 
2007) and shown to be associated with loss of beta-cell function, reduced acute insulin 
response (Groenewoud et al. 2008; Palmer et al. 2008) and increased area under the curve 
(AUC) proinsulin to insulin ratio (Kirchhoff et al. 2008). 
The other two candidate SNPs rs7752906 and rsl569699 are located within the 
same intronic region where rs7754840 is located and are in strong LD with rs7754840 in 
our association study. These two SNPs have not been reported to be associated with type 
2 diabetes in other association studies. In Chinese type 2 diabetic patients, CDKAL l 
rs7756992 with a 50% minor allele frequency has been found to be associated with 18% 
increased risk of type 2 diabetes (Ng et al. 2008). 
4.2.2. Gene KIAA1305 
KIAA genes were initially described in the Kazusa cDNA sequencing project 
which sequenced unknown human genes with long cDNA clones (>4kb) and encoding 
large proteins (> 50 kDa) (Kikuno et al. 2004). K IAA 1305 gene was initially predicted to 
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be a member of this gene family with unknown intracellular functions (Nagase et al. 
2000). According to GeneOntology, it may be an integral component to nuclear 
membrane and provide DNA binding sites. 
There are different techniques to examine the function of KIAA genes (Koga et al. 
2004; Ozaki et al. 2005) and their interactions with other proteins (Nakayama et al. 2002; 
Murakami et al. 2005). One mainstream method is to fuse KIAA genes with a FLAG-tag 
at C-terminal by redesigning mammalian expression vectors (Koga et al. 2004; Ozaki et 
al. 2005), which allows detection of K IAA genes via Western blotting. Another way to 
detect expression of K IAA genes is to utilize immunofluorescence staining of antibodies 
against endogenous KIAA proteins to determine their intracellular localization (Ozaki et 
al. 2005). Alternatively, we can use anti-mKIAA antibodies as bait to detect proteins 
interacting with KIAA proteins by immunoprecipitatioii followed by tandem mass 
spectrometry analysis (MS/MS) (Murakami et al. 2005). Other researchers have used 
yeast two-hybrid method to detect interactions between KIAA proteins and other proteins 
using cytoplasmic domain of KIAA transmembrane proteins as bait (Nakayama et al. 
2002). 
4.2.3. Gene DACHl 
DACH1 gene is one of the vertebrate homologues of Drosophila dachsund and 
plays an essential role in development of organs. Although this gene has not been proven 
to correlate with type 2 diabetes, it is a strong candidate due to its regulatory functions in 
TGF-beta/Smad signaling pathway. The latter plays pivotal role in cancer development 
(Sunde et al. 2006), regulation of insulin gene transcription and pancreatic islet beta-cell 
91 
CHAPTER 4. Discussion 
function (Smart et al. 2006; Lin et al. 2009). Upon signaling of TGF-beta signaling 
pathway through ligand binding, Smad2 and Smad3 proteins, situated downstream of 
TGF-beta pathway, are recruited and phosphorylated by type-I receptor (Wu et al. 2003). 
The phosphorylated Smad2 and Smad3 proteins then form heterodimers with Smad4 
protein in the cytoplasm. The complex is then translocated into the nucleus and induces 
transcription of various cell-growth related genes by binding to Smad-binding elements 
(SBEs) at their promoter regions (Wu et al. 2003). 
Smad protein family has regulatory functions in normal pancreatic beta-cell 
functions. For example, Smad3 protein, co-translated with Smad4 protein, displace Pdxl 
from the insulin promoter, thereby repressing insulin gene expression (Lin et al. 2009). 
Similarly, Smad7 has also been shown to reduce expression of beta-cell products (Smart 
et al. 2006). Additionally, co-administration of TGF-beta 1 in low dose and exendin-4 has 
been shown to markedly increase expression of insulin mRNA level within exocrine 
AR42J cells (Yew et al. 2004). 
D A C H l may also interfere with TGF-beta signaling by interacting with Smad4 
protein to cause repression of Smad3-induced activation of SBE (Wu et al. 2003). 
Besides, D A C H l gene is tissue-specific and has been shown to express in 
neuroblastomas and cell lines derived from pancreas and breast cancer cell lines (Wu et al. 
2003). 
4.2.4 Gene FUCAl 
FUCAl (alpha-L-fucosidase) is an enzyme involved in degradation of human 
fucose-containing glycolipids or glycoproteins. Various types of mutations within the 
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FUCAl gene have been shown to cause deficiency of normal FUCAl enzymes, leading 
to fucosidosis, which is a lysosomal storage disorder due to abnormal accumulation of 
fucose-containing glycolipids and glycoproteins in various tissues (Willems et al. 1999). 
Type 2 diabetes is characterized by energy abundance and increased protein metabolism. 
Thus it is plausible that abnormal pathways implicated in degradation of proteins may 
lead to abnormal protein processing and trafficking which can lead to endoplasmic 
reticulum stress, apoptosis and abnormal growth (Oyadomari et al. 2002; Eizirik et al. 
2008; Song et al. 2008). 
4.2.5 Gene KCNQl 
Several studies have shown previously that various SNPs within the KCNQl gene 
(potassium voltage-gated channel, KQT-like subfamily, member 1) are associated with 
increased risk of type-2 diabetes, including rs2237892 (Unoki et al. 2008; Yasuda et al. 
2008; Hu et al. 2009; Tan et al. 2009). In both Japanese and East-Asian populations 
(Yasuda et al. 2008; Tan et al. 2009), carriers of the risk-conferring homozygous 
genotype rs2237892 (CC) have lower homeostasis model assessment of beta-cell function 
(HOMA-beta) and corrected insulin response (CIR) than non carriers (Yasuda et al. 
2008). Other researchers have demonstrated the risk association of rs2237892 with higher 
fasting plasma glucose (Tan et al. 2009) and OGTT-derived insulin secretion indices 
(Mussig et al. 2009). 
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4.2.6. Gene SLC27A1 
The SLAC27A1 (solute carrier family 27 (fatty acid transporter), member 1) gene, 
also known as the FATPl (Fatty acid transport protein 1) gene has not been reported to 
be associated with increased risk of type 2 diabetes. However, several studies have 
reported correlation between expression of SLC27A1 gene and uptake of fatty acid in 
adipocytes and skeletal muscle cells. These observations suggest that the gene may be 
implicated in insulin-induced obesity and insulin resistance of skeletal muscle cells under 
high-fat condition (Stahl et al. 2002; K im et al. 2004; Fisher and Gertow 2005; Wu et al. 
2006; Gimeno 2007). 
In adipocytes, treatment with insulin can induce translocation of FATPl from a 
perinuclear compartment to plasma membrane, resulting in increased uptake of long-
chain fatty acids and increased synthesis of triglyceride (Stahl et al. 2002; Wu et al. 2006). 
Similar observations have also been made in skeletal muscle cells in response to insulin 
treatment (Stahl et al. 2002; Wu et al. 2006). Control mice fed with a high-fat diet results 
in increased fatty acid uptake by FATPl proteins which competes with glucose entry to 
peripheral cells as energy substrate, thus, leading to insulin resistance notably in muscle 
cells (Kim et al. 2004). In FATPl-knochout mice fed with high fat diet, reduced 
expression of FATPl gene causes reduced fatty acid uptake and restores insulin 
sensitivity and glucose uptake in muscle cells (Stahl et al. 2002; Wu et al. 2006). In 
FATPl-nul l adipocytes or FATPl-knockout mice, decreased transport of fatty acids 
results in reduced synthesis of triglyceride which protects the animal from diet-induced 
obesity. Interestingly, these knockout animals had increased expression of liver-specific 
FATP2 and FATP5 transporter. Based on these observations, the authors speculated that 
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superfluous fatty acids in these animals may be transported via FATP2 and FATP5 
transporters to hepatocytes for degradation via beta-oxidation. Besdies, several target 
genes o f peroxisome proliferator-activated recetor alpha (PPARa) were found to be 
expressed in hepatocytes o f these knockout animals which can increase beta-oxidation 
rate and insulin resistance (Wu et al. 2006). 
Although there has been no report on the risk association of type 2 diabetes with 
the candidate SNP rs3827011 (19:17471857bp, forward strand), a nearby SNP rs3746318 
located in the 8"、intron of FATPl (19:17472261bp, forward strand) is associated with 
plasma concentration and relative distribution of LDL- I and LDL- I /LDL- I I I ratio 
(Gertow et al. 2003). This series of findings strongly suggest that this gene may be 
implicated in l ipid metabolism to influence risk of obesity, insulin resistance and possibly 
type 2 diabetes, especially under high-fat condition. 
Diabetes and obesity - a prototype of energy dysregulation 
Using an innovative computational method, I have discovered 6 candidate genes 
implicated in DNA-protein biding and gene transcription (DACHl) , cellular growth and 
development ( C D K A L l ) , nuclear membrane component (KIAA1305), protein 
degradation (FUCAl ) , insulin secretion (KCNQl) , fatty acid transport and lipid 
metabolism (SLC27A1). Of note, 2 o f these 6 genes have been confirmed to increase risk 
o f type 2 diabetes in multiple populations (KCNQl and CDKAL l ) . The ability of my 
method to select these confirmed type 2 diabetes genes lends support to its robustness and 
potential util ity. Furthermore, the functions of these 6 genes also appear to have 
complementary roles in the regulation of pancreatic beta cell development and growth, 
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l ipid transport and intermediary metabolism which are major pathways implicated in 
obesity and diabetes. While functional studies are needed to confirm these hypotheses, 
the highly significant joint effects of these genetic variants further suggest that these 
candidate genes may work in concert to increase risk of type 2 diabetes in a 
multiplicative manner. 
4.3. Limits and improvement of this study 
Bias during classification of neurons using K-means clustering 
In this study, I have used my skills and knowledge in computation to improve 
sample classification and apply decision algorithm to discover novel genetic variants 
from a database consisting of 16 phenotypes and over 1800 SNPs located in 560 genes or 
intergenic regions. While these novel findings are biologically plausible, several 
methodological issues need to be discussed. 
Although K-means clustering can be used to improve neurons classification on 
the SOM grid, it can only searches spherical clusters with roughly equal number of 
members (Vesanto and Alhoniemi 2000; Wang et al. 2002). Thus, random application of 
K-means clustering may generate biased result. To address this limitation, hierarchical 
clustering with an appropriate cut-off threshold for between-class distance is more robust 
than K-means clustering when dealing with nonspherical clusters (Vesanto and 
Alhoniemi 2000) and could be used as a substitute of K-means clustering. 
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Insufficient samples may lead to false positive discovery 
Another limitation is the possibly insufficient number of samples in our 2-stage 
experiments. After excluding low-quality samples and partitioning the samples, each 
subset contains 300-400 samples, which can give rise to false positive or false negative 
discovery. Nowadays, more appropriate design of genetic association studies calls for 
more than one thousand samples for each stage and frequently requires prior power 
calculation. While some of the novel genes have been discovered in large consortium, 
there is a need to balance between the cost of the study and the robustness of the analysis, 
leaving aside the small percentage of explained variance averaging only 10-30%. 
To date, most of the genetic association studies have adopted chi-square test or 
regression analysis to discover novel SNPs with adjustment for p values. In my analysis, 
despite the smaller sample size, I have improved the homogeneity of the sample using a 
hybrid classification method. Importantly, the top SNPs discovered by either 2-stage 
analysis using random forests plus chi-square test or double chi-square test agreed 
perfectly after adjustment for p values for multiple comparisons in the method using chi-
square test alone. While only a small portion of candidate SNPs selected by these 2-stage 
analyses were found to be significant when they were tested in the modified original 
sample set (Table 3.2 & 3.4)，it remains possible that the latter method was not robust 
with both false positive (type 1) and false negative (type 2) errors. 
Further more，the known function of the final six genes embracing the eight 
candidate SNPs in this study appear to be biologically plausible and clinically relevant to 
type 2 diabetes. Clearly, further studies in functional genomics wi l l be needed to confirm 
their functions and interactions. In addition, it is obvious that the detection power of our 
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two-Stage approach — either purely chi-square test or random forests plus chi-square 
test — is lower than a one-stage approach in the modified original sample set, as 
indicated by the lower p value in the larger sample (Table 3.4). Nevertheless, the 
replication of some of the candidate SNPs in the 2-stage analysis despite smaller sample 
size adds weight to their significance. 
To address these issues of power, sample size and false signals, hundreds or even 
thousands of iterations in training process of random forests may be required. Instead of a 
two-stage approach, a single-stage association study in the original sample set earned by 
random forests may have higher power to detect candidate SNPs. Apart from using large 
sample size to apply random forests to select candidate SNPs, it is also preferable to 
decide on certain threshold for SNP screening in order to determine significance of SNPs, 
such as a threshold on the p-value of importance index involved in the training process of 
random forests. 
To detect joint effects of SNPs requires adjustment on the original approach 
In the 2-stage analysis using random forests and chi-square test, chi-square test 
was used to validate the SNPs selected in the first stage and compute its significant level 
Although p-value is the 'golden standard' used to discover candidate SNPs in an 
association study, the approach based on purely chi-square test may deviate from the 
nature of random forests and cannot detect any joint effect of SNPs in the second stage. 
Since random forests have the ability to detect joint effects or interactions between 
variables, it is necessary to carry out an iterative approach by random forests in a single-
stage association study to detect disease-related SNPs instead of a two-stage association 
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Study, which allows discovery of joint effects of candidate SNPs. As mentioned before, a 
simulation study should be applied in advance to estimate the threshold of significant 
level when using random forests instead of using the p-value in the chi-square test. 
4.4. Conclusion 
In this post-GWAS era, most researchers face the challenge of analyzing theses 
complex datasets and apply clinical meaning to the findings. While some advances in 
SNP discovery have been made using large consortium, multiple stage testing and 
replication studies, these strategies are costly and not without limitations. The major 
challenge in understanding complex diseases relates to the phenotypic and genotypic 
heterogeneity which can give rise to large number of false positive and false negative 
signals in association studies. 
In my thesis, I have used a combination of SOM and the K-means clustering to 
improve the classification of the samples in order to reduce the phenotypic heterogeneity. 
In a 2-stage experiment, I innovated a hybrid method to use decision-tree based 
algorithms (random forests) and chi-square test to discover 8 SNPs of 6 candidate genes 
with plausible biological functions in type 2 diabetes. While further replication and 
functional studies are needed to confirm these findings, my findings have provided an 
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